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Studies were conducted to investigate the effects of in ovo injection of selenium 
(Se) either as seleno-methionine (Se-Met) or sodium selenite (Na2SeO3) into the yolk of 
incubating eggs on tissue Se concentration, embryo livability, lipid peroxidation, immune 
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solutions providing 0, 2.5, 5, 10 or 20 μg Se/egg, no detrimental effects on embryo 
viability at 20 days of incubation were noted. The effects on tissue Se concentrations 
suggested that Se-Met and Na2SeO3 were metabolized differently by the chick embryo. In  
a subsequent study using injection doses up to 60 μg/egg,  a greater linear response  in 
tissue Se was obtained with Se-Met, compared with Na2SeO3  (P < 0.01). Minimal 
changes in heart and breast muscle Se concentrations were noted above the 40 µg dose 
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had little effect on embryo viability. Injecting Se-Met resulted in greater tissue Se 
accumulation than Na2SeO3 at 20 days of incubation. In another study with broiler eggs 
using injection doses up to 40 μg Se/egg, Se-Met injection resulted in higher hatchability, 
reduced lipid peroxidation in the lung and heart muscle of the embryos after 20 days 
incubation and higher Se concentrations in heart and breast muscle of hatched chicks 
through 7 days and in lung through 21 days of growth. In a feeding trial with broiler 
breeder hens, adding 0.3 mg/kg of Se as Se yeast or Na2SeO3 to the diet improved tissue 
Se status at hatching of progeny chicks. Taken together, these results indicate that 
injection of Se into the yolk of incubating eggs may be useful for enhancing Se status 
during embryonic and early post-hatch development. Therefore, the improvement in Se 
status using this method in conjunction with dietary Se supplementation of breeder hens 
would be much greater than with only using dietary supplementation. 
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CHAPTER 1: INTRODUCTION 
 
 
Selenium’s role in animal health and nutrition was first recognized in the 1930’s 
as a toxic principle that occurred in feed ingredients. Consumption of seleniferous plants 
from certain areas in South Dakota has caused major problems to poultry raisers as 
hatchability and growth performance were affected. Franke and Tully (1935) first 
described the toxic effects of selenium in chickens grown in certain localities in South 
Dakota, USA. Farmers raising these chickens complained of low chick hatchability, 
hatched chicks had greasy down that never became fluffy and when higher hatchability 
was obtained, chick livability was lower. Tully and Franke (1935) attributed the inhibited 
growth of chicks and reduced egg production from toxicants that naturally occur in grains 
grown from “alkalied” areas.  In a related study, Franke and Tully  (1936), induced the 
teratogenic effects in chick embryos using selenite injected into the aircell with a reported 
lethal dose of 50% (LD50) at 0.7 ppm. However, even at a low concentration of 0.01 ppm, 
embryonic abnormalities were observed. In 1958, Gruenweld described the histologic 
changes that occurred in embryos <5 d of incubation hatched from hens fed a diet 
containing 45% wheat and supplemented with Se at 17 ppm. The primary visible effect in 
the embryo was necrosis of the cells in the brain, spinal cord, optic cups and lens vesicles 
and in the mesenchyme of the limb buds and somites of the tail region. 
Subsequent studies included injecting incubating eggs using different routes of 
administration, Se compounds and stages of development. The toxic effects of Se 
included high mortality and developmental defects. Depending on Se compounds used, 
route and days of injection, these experiments led to different estimates of the LD50. 
Aircell injection resulted in higher death than the yolk sac route. Organic (Se-Met, 
selenocysteine) as well as inorganic (selenite, selenate) forms of Se were used as Se 
sources, however, Se-Met was observed to be more toxic than Na2SeO3 (Palmer et al, 
1973).  Dietary addition of Se at toxic levels to hen diets resulted in decreased in 
hatchability, egg weight and egg production. Eggs that did not hatch after 21 days 
showed embryos with head and neck enlargement (Ort and Latshaw, 1978). 
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Se toxicity occurs when the body’s ability to excrete excess Se is compromised. 
However, “since the physiological basis of selenosis has been defined and the 
biochemical indicators have not been identified, it is difficult to distinguish levels of Se 
that are safe and beneficial from those that are potentially harmful to health” (Ralston et 
al, 2008).  
Although Se was first associated with toxicity, in 1950’s, the importance of 
selenium in the diet was elucidated when it was deemed essential in the prevention of 
liver necrosis in rats. Hence, its essentiality was established. This was further 
strengthened in the 1970’s when Se was found to be an essential component of the 
enzyme glutathione peroxidase (Rotruck et al, 1973).  Since the essentiality of Se in the 
animal diet had been established, more research was then focused on the requirement to 
prevent deficiency effects.  Deficiency of Se in the poultry diets has shown to cause 
several pathological conditions that can impact growth and development.  
Normally, Se is added to the animal’s diet using inorganic Se (Na2SeO3 or 
Na2SeO3). However, in 2000, the United States Food and Drug Administration (FDA) 
approved the use of Se yeast as an organic Se source of which the major Se component is 
Se-Met.  It has been reported that Se is readily transferred from breeder hens to the eggs 
and, thus, to the embryo (Cantor et al., 1974; Paton et al., 2002). However, the amount of 
Se that can be derived from the hen’s diet is limited, because the maximum level of 
dietary Se supplementation is limited to 0.3 ppm by the FDA.  
One unique way of introducing nutrients to the incubating embryo is through in 
ovo injection. Studies have shown that in ovo injection of nutrients, such as carbohydrate, 
proteins, vitamins and amino acids as well as vaccines, can enhance growth and 
development of the embryo, improve energy status, promote early gut development and 
improve immune status, as well as alleviate the stress of hatching (Foye et al, 2007; Tako 
et al, 2005; Gore and Qureshi, 1987; Ohta et al., 2001; Johnston et al., 1997; Sharma and 
Burmester, 1984).  
The objective of this research was to study the effects of in ovo injection of high 
levels of Se either as Se-Met or Na2SeO3 in fertile eggs at 10 d of incubation on tissue Se 
concentrations in both embryos and hatched chicks, embryo viability, lipid peroxidation
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and immune responses during post-hatch development.  
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CHAPTER 2: REVIEW OF LITERATURE 
Historical Background of Selenium 
Records of selenium-related illnesses in animals date back to Marco Polo’s travels 
to western China (1271–1295) (Spallholz, 1994). Polo attributed the loss of hooves and 
hair in horses to the consumption of poisonous grasses that researchers now believe 
contained high concentrations of Se. However, the element Se was not discovered until 
1817 when Swedish scientist, Jons Jakob Berzelius isolated and identified it “in the sulfur 
obtained by sublimation from the iron pyrites of Fahlun” (Turner, 1835). Se is named 
after the Greek goddess of the moon, Selene, because chemically it is similar to the 
element tellurium, a name derived from the Latin tellus meaning Earth.    
In the 1800s, “alkali disease” was documented in grazing livestock that had 
access to alkali seeps and high salt concentrations in the U.S. upper Midwest (e.g., 
Nebraska, South Dakota). Symptoms included emaciation, loss of hair and hooves, signs 
of anemia, liver cirrhosis, and skeletal erosion.  Not until 1935 was the underlying cause 
of “alkali disease” identified as Se toxicity. Franke and Potter (1934) proved this 
association by experimentally reproducing similar symptoms in rats by feeding them 
selenite or selenate.  Separately, Moxon (1937) reported another disease affecting the 
nervous system of cattle and sheep, which he called “blind staggers,” since affected 
animals tend to exhibit unsteady gait. He further suggested that these animals had 
ingested plants that were accumulators of high concentrations of Se. 
Selenium was considered to be a toxic element until 1957, when Schwarz and 
Foltz showed it was an essential trace element based on experimental evidence that liver 
necrosis in rats can be prevented when their diets contain brewer’s yeast but not torula 
yeast. Brewer’s yeast differentially contains Se, which together with vitamin E and 
cysteine, can prevent liver necrosis, Se being what is now known as Factor 3. In separate 
studies Schwarz et al. (1957) and Patterson et al. (1957) also showed that Se can prevent 
exudative diathesis (ED) in chicks. In addition, Se therapy was shown to prevent diseases 
like muscular degeneration, which occurs naturally in lambs (Schubert et al., 1961) and 
calves (Muth et al., 1958; Schubert et al., 1961). In relation to these, Thompson and Scott 
(1970) concluded that Se is essential for growth of chickens independent of its function
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as a substitute for vitamin E. Concurrently, Rotruck et al. (1973) and Flohé et al. (1973) 
discovered the selenoprotein glutathione peroxidase (GSH-Px), the activity of which is 
dependent upon tissue Se uptake. This discovery confirmed the essentiality of Se in 
animal and human health. To date more than 20 selenoproteins (Arthur and Beckett, 
1994) have been discovered, each of which is tissue specific and dependent on Se 
availability.  
Extensive studies have been conducted to investigate the metabolic effects of Se 
in both animals and humans, but it was not until 1974 that the FDA approved the 
inorganic Se (sodium selenite) for use as a dietary feed supplement for poultry and 
livestock (Leeson and Summers, 1991). In 2000, the FDA approved the use of organic 
selenium in the form of Se yeast (Sel-Plex®, Alltech Inc., Nicholasville, KY), the 
primary Se component of which is seleno-methionine (Se-Met). 
Biochemistry of Selenium 
Selenium is classified as a metalloid, having the characteristics of both the non-
metal and metal elements. With an atomic number of 34 and a molecular weight of 78.96, 
it is a member of Group VIA on the periodic table together with oxygen, sulfur, tellurium 
and polonium. Of these elements, sulfur is very similar to Se both in its chemical and 
physical natures (Table 2.1, Figure 2.1), nevertheless in vivo there are differences and one 
cannot always substitute for the other (Shamberger, 1983). For example, in mammals Se 
tends to be reduced, whereas sulfur is usually oxidized. In terms of its relative acidity, 
hydrogen selenide (H2Se) is more acidic than hydrogen sulfide (H2S). Under physiologic 
pH, cysteine is protonated, whereas selenocysteine (Se-Cys) is usually in a dissociated or 
deprotonated form. 
Currently, both inorganic and organic Se are widely studied and used as feed 
supplements. Substances are classified as inorganic if after combustion of live tissues the 
remaining ash is predominantly in the form of oxides, carbonates, or sulfate (Underwood 
and Suttle, 1999). Inorganic minerals were traditionally added to feed, but because of the 
antagonism that exists between salts and other components of the digesta its 
bioavailability is often compromised leading to lesser absorption of specific minerals.The  
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organic form of minerals implies that they are bound principally to an organic substrate 
(Radcliffe et al., 2007). Organic Se in the form of Se-Met (Combs and Combs, 1986) is 
the natural form of Se normally ingested by animals from plant-based ingredients. 
Furthermore, Se-Met is the predominant Se species present in the organic Se yeast. 
Selenium exists in four oxidative states: selenide (Se-2), elemental Se (Se0), 
selenite or selenous acid (Se+4, SeO3-2) and selenate or selenic acid (Se+6, SeO4-2). These 
valance states are important because they affect both selenium’s solubility in water and 
its absorption in the intestine.   
 
Table 2.1. Comparison of sulfur and Se compounds. 
    Sulfur          Selenium 
 Oxidation State                     --------------------- Inorganic forms -----------------------------  
-II                                            Hydrogen sulfide (H2S)          Hydrogen selenide (H2Se) 
  0    Elemental sulfur (S0)      Elemental selenium (Se0) 
IV    Sulfite (SO3-2)       Selenite (SeO3-2) 
VI    Sulfate (SO4-2)                 Selenate (Se4-2) 
                                                  -------------------- Amino acids forms ------------------------ 
-II Methionine         Selenomethionine  
-II                                              Cysteine                                    Selenocysteine                              
Adapted from Jacques, (2001). 
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Figure 2.1.  Structure of sulfur- and methionine – amino acids. 
            H                 H 
H3N+     C    COO-    H3N+    C    COO- 
 CH2                 CH2 
           CH2    S   CH3                         CH2    Se    CH3 
  Methionine      Seleno-methionine 
 
            H                 H 
H3N+    C    COO-    H3N+    C    COO- 
 CH2                 CH2 
           SH                                      Se     
Cysteine      Selenocysteine 
Adapted from Schrauzer (2000), with modifications. 
 
Selenoproteins 
  Selenium can be incorporated in either an enzyme or protein subunit (i.e., as a 
selenoenzyme or selenoprotein). The name “selenoprotein” is reserved for those Se-
containing proteins in which the Se has a specific biochemical function. This is in 
contrast to Se-containing proteins in which the sulfur amino acid were replaced  by their 
Se analogs. During the synthesis of selenoproteins the UGA (the stop codon code in 
protein synthesis) is recognized as an insertion codon for the Se-Cys residue (McKenzie 
et al., 2002) instead of a stop codon to terminate protein synthesis. The biochemical
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function of selenoprotein is dependent on the type of enzyme with which it is associated.  
There are thought to be between 30 to 50 selenoproteins; of these more than 20 have been 
identified (McKenzie et al., 2002). Of those identified, the most characterized are 
glutathione peroxidase  (GSH-Px, glutathione: H2O2 oxidoreductase, E.C. 1.11.1.9.) 
(Mills, 1957), thioredoxin reductase and iodothyronine deiodinase (Table 2), which play 
roles in antioxidant defense, redox cycle and hormone regulation. 
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Table 2.2. Some mammalian selenoproteins and their proposed functions. 
Selenoproteins              Tissue, cellular distribution, functions 
 
Glutathione peroxidase (GPx) 
         Cytosolic GPx (GPx I)                H2O2+2GSH 2H2O +GSSG                        Many tissues and cell, cytosolic 
Plasma GPx (GPx II)                H2O2+2GSH 2H22O +GSSG                   Plasma, kidney, GIT, thyroid,    
Gastrointestinal GPx (GPx III)         H2O2+2GSH 2H22O +GSSG                   Gastrointestinal tract, antioxidant 
Phospholipid hydroperoxide            ROOH +2GSH  ROH +2GSSG +H2O     Many tissues and cells, testes; cytosolic   
                         GPx (GPx IV)                                                                                              and membrane  
         Epidiymal-androgen-related protein    H2O2+2GSH 2H2O +GSSG                      Structural form of spermatozoa 
                 GPx (GPx V) 
         Olfactory GPx (GPx VI)                 H2O2+2GSH 2H2O +GSSG                       Embryo and olfactory epithelium 
 
Iodothyronine deiodinase      
         Types I and II       Catalyzes the conversion of T4 to 3,5,3’ T3 
         Types I and III       Catalyzes the conversion of T4 to 3,5’3’   
reverse T3  
Thioredoxin reductase                       Multiple roles associated with its role as part 
TrXR1, TrXR2 and TRβ                        of dithiol-disulphide oxidoreductase system 
 
Adapted from Kohrle et al., (2005) and Jacques (2001). 
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Selenium Metabolism 
Although both organic and inorganic Se are metabolized in different ways, they 
both first must be converted in the erythrocytes to selenide (H2Se), which supplies the 
active Se form used in selenoprotein synthesis (Sunde et al., 1997). Several factors can 
affect the metabolism of Se: its chemical form; the presence of sulfur, arsenic, metals, 
microorganisms, vitamin E; and Se status (NRC, 1983).  
Se-Met follows the methionine pathways of metabolism (McConnell and Cho, 
1965) and thus is kinetically similar (Wolffram et al., 1989) in that methionine crosses 
the luminal membrane via the electrogenic Na+-dependent neutral amino acid transport 
system. Animals cannot synthesize Se-Met, so it must be acquired through diet 
(Schrauzer, 2000).  
Recently, using mouse liver, it was established that the Se-Met is directly 
metabolized to monomethylselenol by the γ-elimination enzyme  (Nakamuro et al., 2000).  
This mechanism may explain why Se-Met is metabolized quickly to form 
trimethylselenonium (TMSe). Mainly found in cereals and forage crops, Se-Met can 
replace methionine (Met) because tRNAMet cannot distinguish Met from Se-Met 
(Schrauzer, 2000). Accordingly, the importance of Se-Met lies in the fact that even 
though both selenite and selenate can be used for selenoprotein formation it is only Se-
Met that can be can directly incorporated into bodily proteins (Figure 2.2).  
There are two pathways involved in the catabolism of Se-Met: 1) transulfuration 
(Beilstein and Whanger, 1992), or 2) transamination-decarboxylation (Mitchell and 
Benevenga, 1978), more commonly known as transmethylation. Transulfuration involves 
the production of Se-Cys via the selenocystathione and subsequently glutathione (GSH), 
thus leading directly to GSH biosynthesis from homocysteine.  To rid the biologic system 
of homocysteine, the transulfuration pathway is upregulated such that GSH synthesis is 
enhanced while transmethylation is downregulated (Matte, 2007). Previous studies show 
that an increase in homocysteine levels can be associated with certain pathologic 
conditions. 
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Selenite is reduced to selenide by selenoglutathione and glutathione 
selenopersulfide, whereas Se-Met and Se-Cys are metabolized to hydrogen selenide by 
the enzyme β-lyase (Ip, 1998). In the liver, Se-Cys is metabolized to serine and selenide. 
Selenide can then be used as follows: 1) to synthesize selenoproteins, or 2) methylated to 
dimethyl selenide (DMS) and TMSe ion.  The TMSe form can either be exhaled (via the 
lungs) or excreted (via urine) (Fairweather et.al., 2010).  Since Se-Met can be directly 
degraded to methylselenol (CH3SeH) by the enzyme β-lyase, this metabolic process can 
be achieved by the presence of the vitamin B6-dependent enzyme, cystathionine β-
synthase. 
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   Selenite    Selenate 
Figure 2.2. Seleno-methionine biosynthesis in plants, marine algae and brewer’s yeast. 
Adapted from Schrauzer (2000) (Copyright ©2000 American Society for Nutrition). 
   + GSH    + ATP 
Selenoglutathionetrisulfide Adenosylphosphoselenate 
Selenide 
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Selenium Absorption 
The amount of Se that is absorbed and how the body utilizes it depends on 
whether the form of Se is organic or inorganic (Mahan, 1994). There are three possibly 
methods of Se absorption: 1) inhalation, 2) ingestion, and 3) absorption through the skin. 
Although to date the metabolism of Se in birds has not been thoroughly studied (Wilson 
et al., 1997), in general, ingested Se is thought to be absorbed in the small intestine, 
particularly the duodenum, via the Na+-dependent neutral amino acid transport system 
(Vendeland et al., 1994) and is then distributed to almost of cells in the body.  As 
demonstrated using a rat model, apparently no absorption occurs in the stomach 
(Whanger et al., 1976). Absorption however, is dependent not only on the chemical 
species and amount ingested (Shamberger, 1983) and Se status of the animal (Daniels, 
1996), but also on the absorption site (i.e., duodenum). By using everted rat intestine, the 
isolated brush border membrane vesicle (BBMV) fraction revealed differences in kinetics 
between Se forms.  For example, response to selenite was found to be curvilinear, 
whereas the response to Se-Met was linear. Selenite was present at concentrations almost 
37-fold higher than selenate (Vendeland et al., 1994) and Se-Met is 14-fold higher 
selenate In a study using mallard ducks injected with selenious acid, it was shown that 
visceral tissues responded to injection in a triphasic manner (i.e., a rapid rise, a decline, 
and another rise after 24 h), whereas Se concentrations in the brain increased 
continuously from 15 min to 24 h post-injection (Wilson et al., 1997). In this same 
experiment, the ovaries tended to accumulate Se more so than did visceral organs. The 
investigators concluded that ovaries may preferentially absorb selenium, which could 
potentially lead to reproductive abnormalities or embryo toxicity. Furthermore, they 
suggested the human placenta could possibly protect against toxicity, a mechanism that is 
not found in egg-laying species.  
Study of the uptake of Se in the form of selenate in the brush border membrane of 
human placenta has shown that the transport system is similar to that of the sulfate 
pathway (i.e., Na+-independent), which is also inhibited by chromate, molybdate, 
tungstate and sulfate (Shennan, 1988). Thus, Se is a competitive inhibitor of sulfate    in 
the microvilli of human placenta. 
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In terms of Se form, Se-Met has been found to be more efficiently absorbed than 
the inorganic selenite, which is absorbed via passive diffusion (Wolffram, 1999).  
Swanson et al., (1991) found that 74Se from selenite was 84% absorbed compared to 98% 
for Se-Met after subjects consumed a daily diet containing 87 μg dietary Se, 94 g fat, 304 
g carbohydrate and 98 g protein. The Se from inorganic sodium selenite, sodium selenate 
and calcium selenate were shown to be absorbed at the same rate in chicks in trials using 
high levels of inorganic Se supplementation, with the kidney having the highest Se 
concentrations (Echevarria et al., 1988a,b). 
The presence or absence of other nutrients affects the uptake or absorption of Se.  
Mykkanen and Wasserman (1989) concluded that vitamin-D deficiency could impair 
selenite absorption in chicks based on analysis of duodenal BBMV in rachitic chicks and 
vitamin-D-treated rachitic chicks. Similarly, high doses of vitamin A (Combs, 1976) or 
vitamin C (Combs and Pesti, 1976) can also lead to increased intestinal uptake of Se. 
Transport and Storage 
In general, trace minerals have specific carriers once they are effluxed from the 
basolateral membrane of enterocytes to the general circulation, which ensure these ions 
do not exist in free form.  After Se is absorbed it is carried in the plasma (Buescher et al., 
1960) bound to plasma proteins (McConnell and Levy, 1962). From there it enters the 
different tissues of the body. Although Se can be found in almost every cell in the body, 
its concentration varies according to the type of tissue as well as the level of Se intake 
(Schamberger, 1983).  
The uptake of Se-Met represents binding whereas the uptake of selenite or 
selenate represents both binding and transport into the vesicle (Vendeland, 1994).  The 
selenite transport system has kinetics similar to that of zinc (Zn) in that it is sodium 
independent and occurs through simple diffusion (Wolffram, 1999).  
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Bioavailability 
Since selenium’s discovery as an essential nutrient the majority of nutritional 
studies, especially those involving poultry, have focused on the dietary effects of sodium 
selenite.  More recently, organic selenium in the form of  Se yeast has been the  subject of 
study because there are indications that the organic form of Se tends to be more 
bioavailable compared with the inorganic form.  Bioavailability is the amount or 
percentage of a substance that passes from the gastrointestinal (GI) tract to the plasma 
under normal physiologic conditions (Wolffram, 1999). Although both Se-Met and 
selenite are converted to selenide, the method by which they are metabolized into Se-Cys 
for incorporation to GPx differs. Se-Met can be incorporated directly into tissue proteins 
and stored which helps elevate the amount of Se-Met that is retained (Henry and 
Ammerman, 1995).  In contrast, although selenite is highly absorbed is not well retained 
in body tissues since its passive mode of absorption is similar to that of a mineral 
(Wolffram, 1999)  
 The bioavailability of selenium has been studied in the prevention of exudative 
diathesis (ED) in chicks (Cantor et al., 1975a).  Using different feedstuffs and Se 
compounds, after 12–21 d of feeding the bioavailability of eight plant-based Se sources 
ranged 65–210% compared with Se from animal origins, which ranged 8–24%.  The 
bioavailability of selenium from the following compounds was as follows: selenate 
(74%), seleno-DL-met (39%), and elemental Se (7%). They further demonstrated that the 
protection against ED is highly correlated with GPx level in chicks fed with selenium. At 
6 and 7 d post-Se-Met supplementation, there was a lack of positive correlation between 
Se-Met and plasma GPx activity. Selenite or Se-Cys was found to be more effective in 
preventing ED than Se-Met. However, in a related study (Cantor et al., 1975b), Se-Met 
was found to be more protective against pancreatic degeneration in chicks compared with 
selenite or Se-Cys.  Cantor et al. (1974) concluded that the bioavailability of selenium is 
determined by the ability of the chicks to utilize selenium for GPx activity and that 
selenite is better utilized for GPx activity than Se-Met, and that Se-Met and selenite have 
different modes of action in chicks with respect to ED and pancreatic fibrosis.  In another 
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study using turkeys, Cantor and Tarino (1982) concluded that Se availability from 
selenite exceeded that of Se-Met based on plasma GPx activity.                                                                                                                                                                                                                                                                                                                                         
Excretion 
Selenium can be excreted from the body via three routes: 1) respiratory, 2) urinary, 
and 3) intestinal. When selenite is metabolized to hydrogen selenide, the TMSe ions 
derived are excreted in the urine, whereas DMSe (a volatile compound) is expelled by the 
lungs (Nakamuro et al., 2000). Generally, the amount of selenium eliminated is 
dependent on the amount and form of dietary Se and its biologic interactions with other 
elements (Schamberger, 1983), such as cadmium, arsenic, copper, silver, manganese, 
lead, mercury, thallium, tellurium, vanadium and bismuth.  
Distribution of Selenium 
A. Plants 
Selenium is taken up from the soil by plants as selenite, selenate or organic 
selenium (Johnson et al., 1967) and incorporated during the synthesis of Se-substituted 
analogues of thiomolecules (Ralston et al., 2007). The predominant form of Se in plants 
is Se-Met (Schamberger, 1983). The Se concentration in plants is dependent on several 
factors including soil pH, oxidation rate of artificial fertilization and rainfall (Surai, 2006) 
as well as sulfur, calcium, phosphorus and nitrogen concentrations (Schamberger, 1983). 
Selenium is delivered to chloroplasts in the leaves through the xylem system. Once Se is 
assimilated it is processed via the sulfur pathway into organic compounds (Surai, 2000).   
Different plants have different capacities for incorporating Se from the soil and are 
categorized accordingly: 1) Se accumulators, 2) secondary Se accumulators, 3) non-Se 
accumulators (Surai, 2006).  The Se accumulators are those that are associated with Se 
toxicity symptoms observed in the initial stages of Se research. These plants, grown in 
seleniferous soils, tend to accumulate selenium in leaves and stems.  Secondary Se 
accumulators have high Se concentrations even if they are grown in soils with low-to-
medium-Se content. Meanwhile, the non-Se accumulators are plants with less than 25 
ppm Se and which do not accumulate Se in excess of 100 ppm even if they are cultivated 
in highly seleniferous soils (Terry et al., 2000). In an experiment using duckweed, Se 
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from selenite tended to accumulate three times faster than from selenate (Peterson, 1967). 
In a translocation experiment conducted by Gissel-Nielsen (1976), it was shown that 
after30 min more than 15% of Se was translocated from selenite compared with more 
than 80% from the amino acid fraction, which he surmised was most likely in the form of 
Se-Met. Overall, plant-based Se tends to accumulate in animal tissues whereas selenite 
does not (Cantor et al., 1974).  Plant-derived Se in forages and grains is mainly composed 
of organic forms such as Se-Met and Se-Cyst although Se-Met represents 50% of 
naturally occurring Se (Olson and Palmer, 1976). In animals, the Se component of Se-
Met must be released from the amino acid complex and the Se converted to selenide 
before it can be converted to Se-Cyst (Olson and Palmer, 1976). 
B. Soil and Geographic Location 
In general, the concentration of minerals in plants reflects the mineral content of 
the soil.  When soil mineral concentration is low, either plants will have lower mineral 
concentrations in the seed/grain or plant growth will be reduced, or both. The 
concentration of Se in soil varies but is thought to average about 0.01 ppm (Bohn et al., 
1985).  Kubota et al. (1967) studied the relationship of soil and Se in forages and feed 
crops in the United States. They categorized the states according to soil Se level (Figure 
2.4). Soils in South Dakota, Nebraska, Kansas and Colorado tend to have higher soil Se 
concentrations (2–10 ppm) because they are derived from cretaceous shales, whereas 
soils from the Great Lakes, Northwest and Southwest have low Se concentrations (<0.05 
ppm) because they are derived from volcanic deposits or well-washed coastal deposits. 
The regional distribution of soil Se is important because it correlates to the Se content of 
local forages and grains. Notably, low-Se areas, such as Illinois, Ohio and Indiana, are 
where most of the corn and soybean meal used by the poultry industry is sourced. 
Likewise, some areas in the southeastern United States where the soil Se is either variable 
or low also have high concentrations of poultry producers.   A survey conducted by 
Cantor et al. (1997) on Se levels in corn from 10 states (Delaware, Illinois, Indiana, Iowa, 
Kentucky, Maryland, Minnesota, Nebraska, Ohio and Virginia) and soybean meal grown 
in 18 states (Alabama, Arkansas, Delaware, Georgia, Illinois, Indiana, Iowa, Kansas, 
Kentucky, Maryland, Minnesota, Mississippi, Missouri, Nebraska, North Carolina, Ohio, 
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South Carolina and Virginia) revealed that state averages for Se levels in corn 
ranged from 0.024–0.428 ppm, whereas for soybean meal the range was 0.06–0.80 ppm.  
         C. Tissue Se Distribution 
After absorption, tissue retention of Se is dependent on several factors including 
type of tissue/organ; amount and form of dietary Se; length of feeding time; and animal 
Se status, species, and age. Tissue concentration is also greatly affected by the amount of 
Se supplemented in the breeder diet; hence maternal plane of nutrition is of significance 
to embryo Se status.  
In the avian egg (using 6 terrestrial bird types), the Se content was found to be as 
follows yolk > chalazae > internal viscous albumen > external liquid egg white 
(Golubkina et al., 2006), which is in agreement with previous studies showing that Se is 
more concentrated in egg yolk (Paton et al., 2002; Edens and Sefton, 2002; Cantor, 1997). 
As for eggshells, studies have shown that it too contains Se although not in 
proportions as high as those of egg contents.  The egg shell might also be an additional 
source of Se for the growing embryo (Surai et al., 2004), which is in agreement with the 
study conducted by Golubkina and Papazyan (2006) in which the concentration of egg 
shell Se decreased (P < 0.01) as the embryo developed in two groups of hens fed diet 
containing 0.3 ppm Se as sodium selenite or Se yeast. The different sources of Se differed 
in the amount of Se that accumulated in the egg hell as well as in the eggshell membrane. 
As previously mentioned, Se is carried to the liver and kidney after its absorption. 
In an experiment conducted by Aspite and Atlavin (1994), 4 h after injecting a 
radioisotope of selenium (75Se) concentrations of Se in chicken tissues were as follows:  
duodenum > liver > kidney > feathers > jejunum and ileum  > spleen  > pancreas  > blood 
 > breast muscle. In contrast, Surai et al. (2006) supplemented quail diet with 0.5 ppm 
organic selenium and found the following Se tissue distribution: kidney > liver > heart = 
lung > breast > leg muscle > brain.  In another study, Se-deficient 4-month-old Wistar 
rats were injected with 0.13 µg Se (75Se) in the vena caudalis on d 1 and d 5 and later 
showed preferential accumulation of Se in the brain, endocrine and reproductive organs 
compared with tissues such as heart, muscle and liver (Behne et al., 1988). 
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Selenium Deficiency 
The essentially of Se in animal diet was reported by Schwarz and Foltz (1957). 
Since then studies on Se deficiency in poultry have also been reported that confirm the 
importance of dietary Se (Edens, 2002, 2001,1996; Edens et al., 2002; Combs and Combs, 
1984; Combs and Scott, 1977; Cantor et al., 1975a,b; Latshaw et al., 1977; Latshaw and 
Osman, 1974; Gries and Scott, 1972). Furthermore, Se deficiency when coupled with low 
vitamin E can be responsible for an array of poultry diseases including ED and nutritional 
encephalomalacia (Noguchi et al. 1973; Combs and Hady, 1991).  
 Certain metabolic disorders can also be linked to deficiency since Se is a 
component of the enzyme iodothyronine deiodinase (DI) types I, II and III.  Se-dependent 
enzyme type I functions in the deiodination of T4 to the metabolically active T3 (Becket 
et al., 1987). In a study by Jianhua et al. (2000), Se-deficient chickens showed significant 
reductions in T3 and elevated T4 levels compared with Se-supplemented chickens. 
Likewise, 5’deiodinase activity was lower. When a monoiodinase inhibitor such as 
iopanoic acid was added to the diet, T3, T4 and 5’hepatic DI activity were diminished to 
levels comparable to those of the control, leading to reductions in weight gain, which 
suggests that dietary Se tends to increase the rate of skeletal muscle breakdown. This 
finding is in agreement with Brown et al. (1981) who concluded that Se supplementation 
in rats increased muscle protein breakdown leading to heavier body weights (BW).  
 Selenium deficiency has also been documented in humans, especially in regions 
where soil Se concentrations are poor leading to low concentrations of Se in staple grains 
and human diet.  For example, in China Se deficiencies in people are associated with 
Keshan disease, which is characterized by multifocal necrosis and replacement fibrosis of 
the myocardium, which can lead to heart failure (Chen et al., 1980; Li et al., 1985).  
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Selenium and Immunity 
Dietary Se plays an important role in all aspects of the immune system (Arthur et 
al., 2003). Selenium is a known component of GPx, which removes lipid hydroperoxides 
and hydrogen peroxide and converts them to water and non-radical alcohols.  GPx 
compounds are found in the different cellular compartments (e.g., cytosol, extracellular 
space, cell membranes). Therefore the antioxidant properties of selenium are present 
throughout the cell as well, participating in immune signaling. 
Swain et al. (2000) reported that feeding broiler chicks with a combination of 150 
IU/kg vitamin E and 0.1 ppm Se as Na2SeO3 significantly increased antibody production 
against Newcastle disease vaccination as measured by ELISA titer. Furthermore, Se plus 
vitamin E combination diets compared with basal diets showed a significant increase in 
leukocyte migration inhibition. This study shows the importance of Se as well as vitamin 
E in increasing the immune status of broilers. Other studies have had similar results 
(Singh et al., 2006; Raza et al., 1997).  
Levkut et al. (2009) suggested that the effect of organic Se in increasing   the 
concentration of circulating T and B cells is important in restoring the leukocyte 
subpopulation in chicks fed a deoxynivalenol (DON)-contaminated diet, leading to 
increases in cellular phagocytic activity. They found increased concentrations IgM+, 
CD44+, CD45+ and MHCII+ peripheral blood lymphocytes in broilers chicks fed a diet 
containing DON + Se yeast (corn with a background of 0.5 mg DON/kg feed) and Se 
yeast supplemented control diet compared with a control diet or mycotoxin-contaminated 
diet without Se yeast addition. Additionally, Se-fed broilers challenged with coccidia 
exhibited enhanced immune response (Colnago et al., 1984) through higher blood packed 
cell volume than chickens fed a basal diet. Leukocytes were retained at the site of 
infection, but were not destroyed. That they were not destroyed by the infection confirms 
their role in protecting the host against the pathogenic effects of the parasite. 
Leng et al. (2003) conducted an experiment comparing the effect of Na2SeO3 and 
organic Se on immune response of layers and reported that organic Se was two times 
better than selenite in eliciting an immune response, as evidenced by an increase in CD3+, 
CD4+  and  CD8+   surface cell  markers.  Surface  cell markers  display the T cells  to  the  
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antigen-presenting cells. The CD3+ marker is present in all T lymphocytes; CD4+ is a 
marker for T helper cells; whereas CD8+ is a marker for cytotoxic T cells.   Furthermore, 
based on the results of the study, they concluded that dietary organic Se enhances the 
immune status of the birds via increased mobilization and ability of immune cells to 
respond to infection. 
Selenium was also reported to stimulate the transformation of T lymphocytes into 
cytotoxic cells in mice (Kiremidjian-Schumacher and Roy, 1998).  Three groups of mice 
were fed a diet containing Se at normal, supplemented or deficient levels: torula yeast 
(0.2 ppm Se), selenite (2 ppm Se) and Se deficient (0.02 ppm Se). Se supplementation 
significantly increased the ability of resting lymphocyte to respond to mitogen 
stimulation; conversely, Se deficiency decreased mitogen stimulation. In another study, 
in vivo activated macrophages from Se-supplemented mice showed an enhanced capacity 
to destroy tumor cells (58.16 vs 49.17%); this cytotoxic ability may be related to the 
chemopreventive properties of selenium (Kiremedjian-Shumacher et al., 1992). In vitro 
testing showed that the neutrophils from Se-deficient mice rats and cattle can 
phagocytose pathogens, but the neutrophils of Se-supplemented animals can phagocytose 
as well as kill pathogens.  
Another method of measuring in vivo cell-mediated delayed hypersensitivity 
reaction is through intradermal administration of phytohemagglutinin (PHA) in toe webs 
of birds. In brief, Biswas et al. (2006) reported that dietary Se at 0.5 and 1 ppm increased 
antibody response to inoculated sheep red blood cells (RBC) and mitogen response to 
PHA measured as foot web index at 4 weeks compared with the basal diet (0.2 ppm Se) 
in Japanese quail; Se treatments had no effect on performance. In contrast, Gowdy and 
Edens (2003) reported that broilers fed organic Se showed less T-cell-mediated wing web 
reaction to PHA compared with selenite-fed birds.  
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Selenium and Poultry  
Selenium can be maternally transferred from breeder hens to eggs to progeny. 
Supplementing poultry diets with inorganic Se, especially in the form of sodium selenite, 
has been a common practice in the poultry industry, because Se was been shown to be an 
essential nutrient in poultry. In 1974 the FDA first approved the use of Na2SeO3 in swine 
and poultry to prevent economic losses due to Se deficiency, which were estimated 
around $82 million (Ullery, 1980; FDA, 1974). In 1978 an amended Se regulation was 
submitted with the following changes: Se can be supplemented up to 16 weeks of age at a 
level not to exceed 0.1 ppm for chickens or 0.2 ppm for turkeys (Ullery, 1980). In 1981, 
the FDA approved the supplementation of selenium at 0.1 ppm to laying hen diets (FDA, 
1981). Ullrey reviewed the basis for this regulation of Se supplementation in animal diets 
in 1992. In 2000, the FDA approved the use of organic selenium in the form of Se yeast 
(Kelly and Power, 1995) in poultry (FDA, 2000; 2002). Se yeast contains a high level of 
Se-Met, a naturally occurring form of organic Se found in plant-based feed ingredients.  
Selenium and Maternal Transfer 
The developing embryo is highly dependent upon the nutrients transferred from 
the dam via the yolk. After the egg is laid, the fertile egg is isolated from additional 
nutritional influences other than simple gaseous exchange (Noble, 1986). The 
contribution of yolk lipids to aerobic metabolism through β oxidation is critical to the 
embryo’s successful development (Surai, 1999).  All of the energy needed by the 
growing embryo is contained in the lipid fraction of the egg contents, which includes the 
yolk (McNabb, 2000). Therefore maternal nutritional status during egg development is of 
critical importance. 
Gaseous exchanges and high metabolic rates during embryonic development can 
lead to the production of reactive oxygen species (ROS) free radicals (Halliwell, 1994). 
These free radicals can cause cellular damage leading to peroxidation.  Antioxidants play 
an important role in combating these substances and providing protection to cells and the 
developing embryo overall (Surai et al., 1996). Antioxidants include vitamin E, vitamin 
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C, and three antioxidant enzymes: superoxide dismutase (SOD), catalase (CAT) and Se- 
containing GPx.   
Selenium Toxicity and the Chick Embryo 
Early embryo nutrition is essential for successful incubation in conjunction with 
appropriate environmental factors and egg quality.  Thus, the nutritional status of eggs, 
i.e., type and concentration of nutrients passed on by the dam to the developing embryo, 
is important before oviposition since development of chicks occurs outside of the 
maternal body. During embryonic development, the yolk is the primary source of 
nutrition. Therefore, the presence of energy and nutrients such as amino acids, vitamins 
and macro or microminerals and other nutrients should be optimum for maximal growth 
and development. One such important micro mineral is Se. The effects of Se on transfer 
from breeder hens to progeny have been previously studied (Cantor and Scott, 1974; 
Paton et al., 2002; Surai, 2000; Pappas et al., 2005; Pan et al., 2007, Latshaw and Osman, 
1975) and its positive influence on post-hatch chicks is well documented.  Cantor and 
Scott (1974) showed that dietary selenium in hen diet does not lead to excessive Se 
uptake in eggs and is required for growth and protection of progeny. Pre-hatch access to 
selenium might help retard peroxidation brought about by the heightened ROS 
concentration during the hatching period, as indicated in previous studies on early 
nutrition (Foye et al., 2007; Tako et al., 2005), which revealed that pre-hatch access to 
nutrients as β-hydroxy-β-methyl-butyrate (HMB) and Zn methionine contribute to 
enhanced jejunal nutrient uptake and digestion as well as improved gut functionality in 
contrast to sham controls. Thus, early feeding may help offset some constraints related to 
hatching.  
 Previous studies have shown that yolk Se concentrations are highest between d 
10–15 of incubation (Paton et al., 2002; Surai, 2000) when dams are supplemented with 
Se from either organic or inorganic sources. During this period, when graded levels of Se 
(0.1- 0.3 Se ppm as Na2SeO3or Se yeast) were supplied to the dam, the net effect for the 
extra embryonic Se levels was significantly higher from Se yeast compared with Na2SeO3 
or no Se due to increased overall Se status of the egg. 
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 Likewise, embryonic Se concentrations were greatest Se-yeast-supplemented 
hens.  Therefore, both the source and dose of selenium greatly affect the Se content in the  
egg, embryo or extra-embryonic fractions.  
In terms of the pro-oxidant property of Se, a study by Ort and Latshaw (1978) in 
which layer diet was supplemented with graded levels of Na2SeO3 (0, 0.1, 1.0, 3.0, or 5.0 
mg/kg Se) revealed that up to 5 mg/kg Se was nontoxic to laying hens, i.e., there were no 
significant effects on egg weight, hatchability or egg production. However, when the 
layer diets were supplemented with 7 or 9 mg/kg Se, egg weight and hatchability 
declined (P < 0.05). Furthermore, the addition of 9 mg/kg Se in the diet significantly 
reduced (P < 0.05) egg production. The only visible defect in embryos that did not hatch 
by 21 d of incubation was an enlargement of the head and neck region attributed in part 
to fluid retention and in part to abnormal tissue development. 
Franke and Tully (1935) first described the toxic effects of Se in chickens grown 
in certain localities in South Dakota, USA. Farmers raising these chickens were 
complaining of low chick hatchability, hatched chicks had greasy down that never 
became fluffy and when higher hatchability was obtained then chick livability was lower. 
Based on their experiments, eggs obtained from the affected farms had 107 / 139 eggs 
that failed to hatch. They reported that embryos exhibited the following malformations 
such as, upper beak stubby or missing, beak crossed, enlargement of head or neck, no 
eyes, and one eye. These low hatchability and embryo anomalies were probably due to 
the supplementary feeds given to the hens. In a subsequent experiment, Tully and Franke 
(1936), attributed the inhibited growth of chicks and reduced egg production from 
toxicans that naturally occur in grains grown from “alkalied” areas.  In a related study, 
selenite was directly injected into the aircell and it induced teratogenic effects on the 
embryo, the LD50 was reported as 0.7 ppm but even a dose as low as 0.1 ppm produced 
these embryonal defects (Franke and Tully, 1936). These defects were similar to those 
seen when laying hens in their earlier studies.  Franke et al. (1937) further studied the 
effects of Se poisoning on hatchability. Toxic grain such as corn, wheat or barley 
containing about 15.15 ppm Se resulted in hatchability that decreased to zero but 
resumption of normal diet after 7 days hatchability was restored. 
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In 1958, Gruenweld described the histologic defects that occurred   embryos <5 d 
of incubation) hatched from hens fed a diet containing 45% wheat and supplemented with 
selenium at 17 ppm. Visible primary effects of Se supplementation transmitted from the 
hen to the embryo was necrosis of the cells in the brain and spinal cord; in the optic cups 
and lens vesicles, in the mesenchyme of the limb buds and in the somites of the tail 
region. These changes could explain the physical anomalies described in the previous 
woks of Franke and Tully  (1935).  
One of the first studies on Se injection to chick embryos was that of Franke et al. 
(1936) who reported that the LD50 (lethal dose) for eggs incubated at d 0 or before 
incubation to be 0.7 mg Se /kg as Na2SeO3. LD50 is a common method for measuring 
substance toxicity and is defined as the dose that kills 50% of the animals exposed – thus, 
the lower the LD50, the more toxic the substance.  Ridgway and Karnofsky (1952) 
studied the effects of 56 metals including selenium on the chick embryo, using two routes 
of inoculation (i.e., yolk and chorioallantoic membrane (CAM)) using a volume between 
0.05–0.2 ml. They estimated the LD50 for Se to be 0.03 mg Se/egg from selenate (H2SO4) 
when injected at 4 d of incubation via the yolk sac. This study produced fewer chick 
abnormalities (10–20%) in the surviving embryos at 18 d of incubation compared with 
those obtained by Franke et al. (1936). On the other hand, when Halverson et al. (1965) 
injected fertile chicken eggs with 0.1 ml solution that contained Se as sodium selenite, 
potassium selenite, sodium selenate or potassium selenate in various concentrations at 14 
d of incubation, an LD50 of 0.5 µg Se/ml was observed for selenite-Se and an LD50 of 
1.8–2.0 µg Se/ml was observed for selenate-Se.  Chicks hatched from these experiments 
showed growth depression but no visible signs of abnormalities except for some instances 
of dorsal swelling of the neck.  
Kury et al. (1967) injected 1034 White Plymouth Rock fertile eggs with selenious 
acid (H2SeO3) or selenite in saline solution via the yolk sac at 80–86 h of incubation.  The 
concentrations used to inject the fertile eggs ranged from 0.010 to 0.025 mg Se/egg (i.e., 
0.2-0.5 ug/g).  These embryos were injected at 4 d of incubation and examined grossly 
at19 d of incubation.  Embryos examined at d 19 of incubation showed both malformed 
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(22%) and normal embryos (78%). In addition, the surviving embryos were anemic, 
characterized by low red blood count and hemoglobin values.  
Palmer et al. (1973) concluded that Se-Met is more toxic to the chick embryo 
when injected via the air cell at a rate of 0.1 ml with the LD50 at 0.13 µg Se/ml (levels of 
Se ranged from 0.0 - 0.4 mg Se/egg). For Na2SeO3, the LD50 was calculated to be 0.3 µg 
Se/ml (levels ranged from 0.0 - 0.8 mg Se/egg).  These investigators suggested that the 
higher levels of toxicity exhibited in this study compared with results of Franke et al. 
(1936) and Halverson et al. (1965) were attributed to the fact that at 4 d of incubation 
embryos are at a more critical stage of development than either 0 h (pre-incubated) fertile 
eggs or 2-wk-old embryos. 
Sukra et al. (1976) reported that a Se injection between 0.1- 0.2 µg Se/ml as 
Na2SeO3 after a mercury injection improved the survival of the embryos more so than 
mercury alone. However, in a more recent study, 6-d-old chick embryos that were 
injected with 0.02 mg Se / embryo as Na2SeO3 all died within 48 h after inoculation 
(Szelezczuk et al., 2004). Table 3.1A and 3.2B list the results of earlier studies involving 
egg inoculations with selenium. 
Most of the studies Se and chickens to date involved the quantification of the 
concentration or distribution of dietary inorganic or organic selenium in the heart, breast 
muscle, liver, kidney, spleen, whole blood, serum (Payne and Southern, 2005; Pan et al., 
2007), eggs, and whole embryo (Paton et al., 2002). “Selenium has been shown to be 
efficiently taken up in the intestinal cells as well as the kidneys but the transporter system 
involved in this uptake has not been identified” (Nickel et al., 2008).  Previous studies on 
brush border membrane uptake of selenium from other species have been inconclusive 
(Leblondel. et al., 2001; McConnell and Cho, 1965; Vendeland et al., 1992; Wolffram et 
al., 1989).    
In a study by Wilson et al. (1997), the kinetics of Se (75Se) in avian species was 
elucidated. Using 1-year-old female mallard ducks, 0.19–0.22 µg per 920 g bird (0.21–
0.24 µg/kg BW) was injected via the wing vein and Se tissue levels were determined 15 
min, and 1, 4, 12 and 24 h post-injection. The rate of Se disappearance or appearance was 
measured in different tissues; over 12 h, Se concentration increased in the visceral organs. 
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Table 2.3A. Summary of embryo studies on pre-hatch selenium injection.  
Reference          LD50,   Incubation    Inclusion rate             Effects 
                                           μg /g             stage (d)          (mL)    
AIR CELL 
route  
Franke et al., 
1936 
 
0.7 
as  Selenite 
 
 
0 
 
0.1 
 
<1 ppm high mortality and 
abnormalities 
Halverson et al., 
1965 
0.5 
as Selenite 
 
1.8–2.0 
as Selenate 
14 0.1  
Depressed growth and some 
neck abnormality seen in 
hatched chicks 
 
Palmer et al., 
1973 
 
0.13 
as Se-Met 
 
0.3  
as Selenite 
 
4 
 
0.1 
 
Se-Met more toxic than 
selenite 
 
Sukra et al., 
1976 
 
0.01–0.02 
as Selenite 
 
3, 5, 9, 15 
 
0.1 
 
d 9 at 0.02 and d 15 at 0.01 
with 83% chick survival 
 
YOLK SAC route 
Ridgway and 
Karnofsky, 1952 
0.03 
as Selenate 
 
4, 8 0.1 10–20% embryo survival at 
day 18 of incubation 
Kury et al.,  
1967 
0.010–0.025 mg  
as Selenite. 
 
 
 
80–86 h 0.02–
0.05 
Anemia,  
72% mortality, 
22% malformed embryo at d 
19 of incubation 
 
Szelezczuk et 
al., 2004 
 
 
 
 
5, 9, 15 
 
0.1 
 
Death within 24 h         
(all embryos) 
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Table 2.3B. Summary of embryo studies on Se supplementation of maternal diet.  
      Reference    Inclusion rate               Effects on 1-d-old embryos 
  mg/kg     
MATERNAL TRANSFER Route 
Ort and Latshaw, 1978            9 mg/kg Se in layer diet       Embryos with head/neck 
                                                 as selenite                             enlargement 
    
 Hoffmann and Heinz, 1988     10 mg/kg Se as Selenite 0.5 µg Se/g in eggs: 
                                                  In mallard diet Decreased hatching; Edema; 
Decreased                                                          
growth;  
Increased GPx activity 
 
25 mg/kg Se as Selenite 1.3 µg Se/g in eggs: 
in the diet              Decreased hatching; 
Edema; Decreased growth; 
Increased GPx activity; 
Increased uric acid 
concentration 
     
10 mg/kg Se as Se-met          4.6 µg/g in eggs:  
Malformations and                                        
increased GPx and succinate 
dehyrogenase (SDH) 
activities   
  Smith et al., 1988                  10 mg/kg Se as Se-Met          0.3 µg Se/g in eggs: 
                                                 in maternal diet                     Decreased growth 
                                                                                             (black-crowned night heron)           
                                                                                           increased hepatic thiobarbituric  
                                                                                           acid reactive substances       
                                                                                             (TBARS)  concentration 
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Selenium toxicity has also been documented in other species such as pigs (Goehring et al., 
1984; Herigstad et al., 1973; Harrison et al., 1983), lambs (Tiwary et al., 2006; 
Caravaggi et al., 1970; Fessler et al., 2003; Gabbedy and Dickson, 1969) and ruminants 
(Kaur et al., 2003; Yaeger et al., 1998).  The LD50 of selenite for sheep has been reported 
to be 1.9+1.2 mg Se/kg BW (Caravaggi et al., 1970; Lambourne and Mason, 1969). 
Intramuscular administration of selenite ranged from 0.45–1 mg/kg BW (Blodgett and 
Bevill, 1987). In lambs up to 14 weeks of age, an oral ingestion of 1–2.2 mg Se/kg BW as 
selenite resulted in mortality (Gabbedy and Dickson, 1970).  According to the study of 
Tiwary et al. (2006), the target organ for Se toxicity in sheep is the heart, as shown by the 
high concentration of selenite.  The authors further concluded that oral exposure to Se as 
Se-Met doubled its bioavailability, yet it was slightly less toxic than selenite. The greater 
tolerance to Se as Se-Met can be attributed to the direct incorporation of Se-Met into non-
functional structural protein as a methionine replacement (Panter et al., 1996). Thus, Se 
from Se-Met is incorporated into organs with a high rate of protein synthesis such as the 
skeletal muscle, which contains almost 50% of the Se pool (Tiwary et al., 2006). 
The effect of Se toxicity in relation to other dietary minerals such as As2O5, silver, 
copper, sulfur, lead sulfate, and mercury has also been studied (Lowry and Baker, 1989; 
Tatum et al., 2000; Jensen, 1975; Halverson and Monty, 1960; Jensen and Chang, 1976; 
Donaldson and McGowan, 1989), but is not the subject of this discussion. 
 
Selenium Toxicosis: Mechanism of Action 
  The exact mechanism of Se toxicosis remains unclear but based on the several in 
vitro studies, selenium, as Na2SeO3 appears to act as a pro-oxidant (Moak et al., 2001; 
Cho, et al., 1999; Stewart et al., 1999; Kithara et al., 1993; Spallholz, 1994). 
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Table 2.4.  Ability of Se compounds to generate superoxide in vitro. 
 Superoxide produced   Superoxide not produced 
 Selenite     Seleno-methionine 
 Selenium dioxide    Selenate 
 Selenocysteine    Elemental selenium 
 Diselenodipropionate    Selenobetaine  
 Diphenylseleide    Potassium-selenocyanate 
Adapted from Mezes and Balogh (2007), Surai (2006) and Spallholz (1994). 
 
 The presence of Se compounds intracellularly can produce superoxide in vitro via 
the catalytic oxidation of GSH (Table 2.4). Painter (1941) attributed the toxicity of Se to 
its ability to react with thiols. Ganther (1968) proposed that the inherent toxicity of Se 
lies in its interaction with disulfide, a process that produces selenotrisulfide (RSSeSR). 
Still later, Seko et al. (1989) showed that superoxide forms when selenite reacts with 
glutathione and then with H2Se (Figure 2.5).  
 
Figure 2.5.   Reaction of selenite to produce superoxide. 
 
 4GSH    GSSG               GSH         GSSG      GSH         GSSG      O2           O2•- 
 
 
SeO32-                               GSSeSG                     GSSeH                    H2Se                     Se0   
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Yan and Spallholz (1993) designed a study whereby they measured the generation 
of ROS using mammary tumor cell line (HTB123/DU4475). Production of superoxide 
was measured using lucigenin- or luminal-amplified chemiluminescence. Their study 
showed a significant increase in the concentration of selenite in the presence of GSH, 
confirming the findings of Seko. Selenite was shown to react with GSH, and other thiols 
compounds, to produce superoxide and to a lesser extent hydrogen peroxide. Se-Met and 
selenate were found to be less cytotoxic to tumor cells than selenite or Se-Cys.  
 
Selenium and Vitamin E   
 
 Vitamin E plays an important role in the normal physiologic function of the 
cellular system as a biologic antioxidant (Tappel, 1973). Vitamin E works in conjunction 
with other nutrients and endogenous factors that provide protection against harmful 
effects of ROS, which are produced during normal cellular metabolism or environmental 
sources (Combs, 1999). One nutrient that works in concert with vitamin E is Se.   
 The mechanism of Se and vitamin E in the prevention of ED has been studied 
(Noguchi et al., 1973) to elucidate its role in cellular membrane insult. According to the 
authors, both vitamin E and Se are necessary for sequestering the lipid peroxides formed 
in the lipid membranes. When Se and vitamin E were supplemented in chick diet, their 
mitochondria and microsomes were found to contain both Se and vitamin E, such that 
lipid peroxidation was completely prevented as measured via thiobarbituric acid reactive 
substances (TBARS) production, e.g. malonaldehyde (Raharjo and Sofos,1993; Noguchi 
et al., 1973). Conversely, the cellular mitochondria and microsomes of chicks whose 
diets were depleted of vitamin E and Se showed that these lipid peroxides find their way 
into all cellular compartments, thus causing damage. Cellular membranes afford little or 
no protection against peroxidation during hatching when the liver contains very high 
levels of lipids. In chicks that were supplemented with vitamin E alone (100 IU/kg), 
peroxidation was almost completely prevented by d 9 however, by d 26 the level of 
malonaldehyde formed was comparable to that in chicks fed the basal diet. Thus, vitamin 
E and Se affect the mitochondria in a similar manner. Vitamin E prevents the chain-
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reactive auto-oxidation of the lipid membranes, whereas selenium destroys any peroxides 
present inside the cytosol of the capillary cell.   Thus, vitamin E has the ability to 
neutralize peroxides where they are produced, whereas selenium via the GSH-Px 
prevents the formation of membrane-destructive hydroxyl radicals (OH) and destroys 
hydroperoxides (Leeson and Summers, 2001).   
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Figure 2.6.  Mode of action of  vitamin E and GSH-Px selenium.  
Adapted from Leeson and Summers (2001) and Noguchi et al., (1973).
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Mechanism of lipid peroxidation 
 
Figure 2.7.  Mechanism of lipid oxidation. 
    Adapted with modifications from: Vickers, (2007) and Combs, G.F. (1999). 
      
 
Mechanism of Lipid Peroxidation 
The biologic membranes that separate cells from their surroundings are chiefly 
composed of lipids and proteins molecules. Thus, a bilipid layer acts as a barrier to the 
free passage of inorganic ions and most other charged or polar compounds.  The 
polyunsaturated fatty acids (PUFA) of biologic membranes are susceptible to attacks by 
free radicals because of the presence of 1-4 pentadiene systems that allow the complete 
abstraction of a hydrogen atom from one of the –CH2 groups in the carbon chain (Combs, 
1999), a process that constitutes the initial stage of lipid oxidation. The abstraction of a 
hydrogen atom leads to the generation of an unstable C-centered free-radical group, 
which later undergoes molecular rearrangement to form a more stable conjugated diene. 
  35 
This conjugated diene is prone to attack by molecular oxygen (O2), thus generating a 
peroxyl radical (ROO˙). When the peroxyl radical abstracts hydrogen from other fatty 
acids, propagation of the lipid oxidation ensues and this chain reaction continues until the 
cellular membrane is completely oxidized to hydroperoxides (ROOH) (Combs, 1999), 
which are then degraded into chain cleavage products in the presence of transition metals. 
When lipid peroxides are present, the bilipid layer losses its integrity leading to 
membrane damage and cell death (Padmaja et al., 1997).  Thus, when cell membranes are 
insufficiently protected from oxidative insult, peroxidation of polyunsaturated membrane 
phospholipids and the inactivation of enzymes can result.  
 This chain reaction mechanism of lipid peroxidation of the cellular membrane 
can be prevented by the antioxidant power of vitamin E, which is also known for free-
radical scavenging. Vitamin E (L-tocopherol) donates phenolic hydrogens to fatty acyl 
free radicals, quenching peroxyl groups and preventing the oxidation of PUFA (Table 
2.5; Combs, 1999).   
 
 
Table 2.5. Mechanism of lipid peroxidation and antioxidative reactions. 
Lipid peroxidation                                Antioxidative reactions 
 
1) HO˙ + RH → H2O + R˙           1) α-TH + ROO˙ → α-T˙ 
2) R˙ + O2 → ROO˙            2) α-T˙ + ROO˙ → Nonradical products 
3) ROO˙ + RH → ROOH  + R˙
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Antioxidant Mechanism 
Surai (2003) listed a number of external and internal sources of free radicals that 
can potentially damage cellular members when produced in amounts greater than the 
biologic system can control (Table 2.6). Halliwell (1994) proposed three mechanisms 
explaining how the ˙OH damage can be prevented via repair systems that include both 
DNA repair, enzymes and proteases, and antioxidant defenses that protect cells from free-
radical attack. The presence of natural antioxidants in cells is one way to ensure that cells 
remain viable in an oxygen-rich environment (Halliwell, 1994). Surai (2003)  divided the 
antioxidant repair system into three levels: Level 1 prevents the formation of free radicals 
by the removal of free-radical precursors via the SOD, GSH-Px and CAT and metal-
binding proteins; Level 2 restricts chain formation and propagation of free radicals via 
vitamins A, C, and E, carotenoids, ubiquinols, glutathione and uric acid; and Level 3 
excises and repairs damaged molecules via the enzymatic actions of lipases, peptidases, 
proteases, and transferases, among others.  
 
Table 2.6. Sources of free radicals. 
Internal      External 
Mitochondria      Cigarette smoke 
Phagocytes      Radiation  
Xanthine oxidase     UV light 
Reactions with Fe and other transition metals Pollution 
Arachidonate pathways    Certain drugs 
Peroxisomes      Chemical reagents 
Exercise      Industrial solvents 
Inflammation 
Ischemia and reperfusion 
Adapted from Surai, (2003).
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Avian Egg Formation 
The complex and highly differentiated parental reproductive cells undergo 
organizational change leading to the formation of the egg from which the embryo then 
develops. Egg formation has two distinct phases: 1) growth and maturation of the germ 
cell, and 2) deposition of the yolk, albumen and membranes (Romanoff and Romanoff, 
1963).  The yolk is produced in the ovary, which contains the germ cells, whereas the 
albumen, shell membranes and the shell are supplied by the oviduct. Thus, the formation 
of the egg starts when the primordial cells migrate into the tissues that are destined to 
become the ovaries.  Egg follicles resemble a bunch of grapes and are composed of 
oocytes and layers of tissues, which include the vitelline membrane, granulosa layer, 
theca layers, loose connective tissues, and superficial epithelial tissues. Follicles increase 
in size as they mature. After stimulation with luteinizing hormone (LH) and follicle-
stimulating hormone (FSH) the largest follicle in the cluster ruptures and an egg is 
released from the ovary into the oviduct, which functions not only as a passageway for 
eggs but also secretes necessary structural components to complete the egg (Romanoff 
and Romanoff, 1963).  The oviduct is divided into several parts: infundibulum, magnum, 
isthmus, uterus, vagina and cloaca (Table 2.7).  On average, it takes about 24–25 h for 
eggs to be formed and laid. 
Table 2.7. Formation of egg in the laying hen. 
Part of Oviduct Function Time spent (h) 
Infundibulum Catches yolk, fertilization 0.25 
Magnum Secretes albumen 3.00 
Isthmus Forms the shell membranes 1.25 
Uterus Calcifies shell 20.75 
Vagina Adds cuticle (bloom) a few minutes 
   
Total  24-25  
Adapted from Ensminger, (1992).
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Yolk Formation 
Yolk formation in chickens begins before the end of incubation and can continue 
for several months or years. Substances that are needed for yolk synthesis are generally 
derived from the liver of the laying hen and are then passed to the chick via the blood 
vessels in the ovary. Yolk formation can be classified into three distinct phases: early, 
intermediate, and final (Romanoff, 1960); it ceases when the oocytes reached 60–80 µ in 
diameter (Romanoff, 1960). During this early phase of yolk development, oocytes are 
encapsulated in a thin membrane or sac called the follicle.  A series of cell-restructuring 
and morphologic changes occur, until the follicular cells increase in height such that they 
are pseudostratified. At this point, yolk formation takes place peripheral and central areas 
of the oocyte. Several changes occur in the cytoplasm that leads to increased 
mitochondrial size. Mitochondria spread out within the cytoplasm and primarily occupy 
the periphery of the oocyte, whereas fat spheres appear in the cytoplasm. The yolk then 
collects towards the center of the ovum. Clear vacuole-containing fluid proteins appear 
underneath the layer of fat spheres when the oocytes are about 1 mm in diameter 
(Romanoff, 1960).  
 The intermediate phase of yolk formation soon follows which lasts about 60 d. 
This is the phase is characterized by slow growth of the oocyte and a gradual increase in 
globule growth. Finally, a rapid oocyte growth ensues during the final phase of yolk 
formation, which is about 6–14 d before ovulation. The final phase is also characterized 
by the appearance of latebra, the concentric white yolk at the center of the alternating  
ring of white and yellow yolk. After the follicle ruptures and releases the ovum, the very 
thin clear vitelline membrane, once completely attached to the follicle, detaches from it 
and totally encapsulates the yolk. The yolk is then released into the oviduct and 
transported via peristaltic action. Along the way the albumen, shell membrane and shell 
are added consecutively, and thus the egg is ready to be laid. 
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Embryo Formation 
Fertilization of the egg occurs in the infundibulum when the sperm penetrates the 
vitelline membrane and directly enters into the germinal disc, which signals the 
completion of second maturation division of the egg nucleus (Romanoff and Romanoff, 
1963) after which both the egg nucleus and spermatozoon undergo distinctive changes to 
become the female and male pronucleus.  In contrast to mammals, in the avian egg, 
polyspermy occurs. Thus, many male pronuclei are found floating within the cytoplasm. 
Only that sperm that penetrates the center of the germinal disc will eventually fertilize the 
egg, leading to a lone male pronucleus. Male pronuclei that do not enter the germinal disc 
eventually disperse, degenerate, and disappear (Stepinska and Bakst, 2006). Mori et al. 
(1991) suggested that in quails, the center point of the germinal disc contains the highest 
level of maturation-promoting factor (MPF), whereas the area in which the remaining 
spermatozoa degenerate and die has no MPF.  
The union of the parent nuclei results in the formation of the segmentation 
nucleus. Segmentation (i.e., cleavage) of the cells marks the beginning of embryonic 
development. Avian eggs undergo meroblastic (partial) segmentation, thus they are 
classified as telolecithal eggs, in which a relatively large amount of yolk is concentrated 
at one protoplasmic pole while living cells are confined to the opposite pole (Romanoff 
and Romanoff, 1963). The first cleavage when egg is in the isthmus. This cleavage leads 
to the two-cell stage until the cells reach the 16-cell stage when the shell membrane 
becomes opaque and arrives in the uterus. By this time, the blastodisc has differentiated 
into central and marginal zones.  The central area is separated from the yolk by the 
segmentation cavity or blastocoele. The formation of the blastoderm occurs when cells 
are at the 64-celled stage division. Soon after, the marginal area disappears and 
cellularization of the periblast begins. The blastoderm differentiates into area pellucida 
and area opaca. It is at the central part of area pellucida, that the primitive streak develops. 
After about 12 h of incubation the primitive streak has increased in length and there is a 
marked growth on the posterior direction (medium streak); at 16–24 h the primitive 
streak is fully developed (definitive streak). The primitive streak regresses after reaching 
its definitive length in relation to the size of the area pellucida, and the  “head-process” 
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begins (Romanoff and Romanoff, 1963). The primordial embryonic body begins to 
develop and the egg is then laid. At this time the blastoderm contains about 20,000 cells 
(Gilbert, 2000). Due to cellular development in mesodermal tissues and the establishment 
of the notochord (the primitive axis of the embryo), the avian embryo exhibits a distinct 
anterior-to-posterior gradient developmental maturity (Gilbert, 2000). In brief, cells of 
the anterior end of the embryo are already differentiating into various organs while the 
cells of the posterior end are undergoing the gastrula phase. 
The formation of primary endoderm (or hypoblast) extends throughout the entire 
area pellucida and into the region of the germ cell. The blastoderm covers the yolk and 
differentiates into two layers during gastrula phase. The first layer is the ectoderm which 
gives rise to the skin, feathers, beak, claws, nervous system, lens and retina of the eye and 
the lining of the beak. The second layer is the endoderm, which produces the lining of the 
digestive tract, the respiratory and the secretory organs (Ensminger, 1992). Therefore, the 
embryo develops within the area pellucida, whereas the cells of the area opaca nourish 
the embryo.  
Extra Embryonic Membranes 
Within 48 h of embryo development after fertilization, the extra embryonic 
membranes begin to develop. Four membranes grow out of the embryo: 1) chorion, 2) 
allantois, 3) amnion, and 4) yolk sac (Romanoff and Romanoff, 1963). The amnion and 
chorion arise from the dorsal folding of extra embryonic somatopleure, whereas the yolk 
sac is derived from the extra embryonic splancnopleure (McGeady et al., 2006). As for 
the allantois, it is derived from tissues that are transferred from the yolk sac to the 
hindgut, probably as a diverticulum of the intestine.  The allantois rapidly enlarges and 
occupies a space between the chorion and amnion (McGeady et al., 2006). As the embryo 
develops, it completely detaches from the extra embryonic tissues except at the umbilicus, 
where the body wall and intestine do not yet close.  
By the fifth day of incubation the yolk sac completely surrounds the yolk (Speake 
et al., 1998).  Because the yolk sac is highly vascularized, it produces blood until the 
hematopoietic system of the embryo is in place, and it absorbs nutrients from the yolk, 
which it transfers to the developing embryo. Although open communication exists
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between the yolk sac and the intestines, no yolk passes to the gut during incubation 
(Romanoff and Romanoff, 1963). Enzymatic products produced by the yolk sac 
endoderm are transferred from the endodermal cells to the blood vessels of the yolk sac 
and then to the embryo. Thus, the yolk sac is mainly responsible for the transfer of 
nutrients needed for energy and tissue growth (Noble and Cocchi, 1990). 
            Yolk lipid uptake begins as a rather slow process during the first 2 weeks of 
incubation; on the third week and final week very rapid uptake ensues. Aside from yolk 
components, other nutrients enter the yolk through the umbilicus, such as albumin 
proteins and water during the last 7 d of embryo development. According to Noble 
(1986), proteins are transported through transmembrane transport, whereas lipids are 
absorbed via phagocytosis.  During the final period of incubation, nutrients enter the 
embryo via the intestines after the embryo swallows the amniotic fluid. On average the 
yolk is composed of 48% water, 17% protein, 33% fat, and 2% carbohydrates (Johnson, 
2000), however these nutrient distributions are widely affected by egg weight, genetic 
strain and hen age (Vieira and Moran 1998). With only 2% of the yolk composed of 
carbohydrates, 90% of the energy needs of the embryo during incubation period are met 
by the β oxidation of fatty acids in the mitochondria and peroxisomes to produce acetyl 
coenzyme A (CoA) (Vieira and Moran 1998; Freeman and Vince, 1974). Before the 
embryo is hatched, the energy produced by β oxidation is mainly used to regulate body 
temperature (Speake et al., 1998), the opposite of what happens during the start of 
embryo development, at which time most energy is spent on tissue growth rather than 
maintenance.  
The amnion is the fluid-filled milieu where the embryo floats; it acts as a 
protective cushion and keeps the embryonic tissues from drying out.  In the latter stage of 
embryonic development before pipping, the amniotic fluid, which contains the egg 
albumin, is swallowed by the embryo for nourishment (Romanoff, 1960) essential to the 
first days of life since this internalized yolk serves as an energy reserve.  
The last of the extra embryonic membrane to appear is the allantois (Romanoff, 
1960), which serves as the embryo’s respiratory organ as well as the storage area for 
nitrogenous waste (Smith, 2007). The size of the allantois increases as the size of the 
embryo increases. As for the chorion, its importance is apparent only after it fuses with 
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the allantois forming the highly vascular chorioallantois (Romanoff, 1960), which 
functions in gas exchange. 
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Table 2.8. Embryonic development during incubation. 
Before egg laying Fertilization, cell division; cell segregation into groups of tissues 
Between laying and 
incubation 
No growth 
Stage of inactive embryonic life 
During incubation 
 First day  (h)       
16  
18 
20 
21 
22 
23 
24 
 
 
First sign of resemblance to a chick embryo 
Appearance of alimentary tract 
Appearance of vertebral column 
Beginning of formation of nervous system 
Beginning of head formation 
Appearance of blood islands – vitelline circulation 
Beginning of eye formation 
 Second day (h) 
35 
42 
 
Beginning of heart formation 
Beginning of ear formation 
Heart begins to beat 
 Third day (h) 
50  
60 
62 
64 
70 
 
Beginning of amnion formation 
Beginning of nasal structure formation  
Beginning of leg formation 
Beginning of wing formation 
Beginning of allantois formation 
Fourth day Beginning of tongue formation 
Fifth day Beginning of reproductive organ formation and sexual 
differentiation 
Sixth day Beginning of beak and egg tooth formation 
Eighth day Beginning of feather formation 
Tenth day Beginning of hardening of the beak  
Thirteenth day Appearance of scales and claws 
Fourteenth day Embryo turns its head towards the blunt end of the egg 
Sixteenth day Scales, claws and beak becomes firm and horny 
Seventeenth day Beaks turns towards air cell 
Nineteenth day Yolk sac begins to enter the body cavity 
Twentieth day Yolk sac completely drawn into body cavity 
Embryo occupies the entire egg space except the air cell 
Twenty-first day Hatching of chick 
Adapted from Ensminger, (1992).
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Preparation for Emergence  
The chick embryo emerges from its shell after 21 d of incubation.  High 
hatchability rates are achieved when the incubation conditions are optimum. Emergence 
of the chick begins when internal pipping commences, which is characterized by the 
embryo breaking the chorioallantoic membrane and the inner shell membrane adjacent to 
the air cell.  Wittmann and Weissenbeck (1980) suggested that the increase in CO2/O2 
ratio in the air cell at the end of incubation acts as a stimulus for pipping. At this point, 
the embryo switches from chorioallantois respiration to pulmonary respiration. A great 
deal of energy from the yolk is utilized in preparing for emergence (i.e., pipping 
movement, body rotation). Pipping is achieved through the coordinated action of the 
twitching of the pipping muscle (muscularia complexus) located at the base of the back of 
the neck and the “egg tooth” of the beak.  Between 15–19 d of incubation the relative 
weights of the pipping muscle and liver increase as the result of increased concentrations 
of glucose, glycogen, and protein in the pipping muscle, a crucial metabolic profile 
change as the embryo prepares for emergence (Pulikanti et al., 2010). The embryo then 
proceeds to break out of its shell by twisting its leg muscle (Moran, 2007). After the 
blood vessels that connect the umbilicus to the shell membranes are completely 
obliterated, the hatching process is complete, and the chick is free. 
Early Nutritional Manipulation 
There is an increasing interest in ways to improve the developing embryo through 
early nutritional manipulation, such as i.e., in ovo administration of nutrients. This 
technique is used to enhance early gut development and may abate the challenges chicks 
encounter during the first few hours post-hatch when delay in feeding or long periods of 
fasting are experienced. Although the amount of research on supplementing breeder diets 
with different nutrients has been increasing, perinatal nutrition has also been gaining 
recognition and is the subject of current studies.  
During the early 1980s and 1990s most in ovo studies focused on the delivery of 
vaccines to the developing embryo. Sharma and Burmester (1984) showed that in ovo 
technology could be successful in vaccinating embryos against Marek’s virus.  These 
investigators developed the basis of the in ovo injection procedures in use today. From 
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the early work of Uni and Ferket (2003) there has been an increased interest in pre-hatch 
feeding. To date sources of protein, carbohydrates, vitamins and minerals (Foye, et al., 
2007; Tako et al., 2005; Ohta and Kidd, 2001) have been administered to the developing 
embryo via the amnion, air cell or yolk sac to improve embryo energy status, hatchability, 
BW and post-hatch performance. In addition, early feeding may help prepare the chick 
gut transition from yolk-derived nutrition to external diet. Also the enhancement of 
intestinal transporters due to in ovo administration of nutrients, such as HMB, may aid in 
early gut maturation leading to the increased nutrient absorptive capacity of intestinal 
cells (Foye et al., 2007).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright © Lizza M. Macalintal 2012 
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CHAPTER 3: EFFECTS OF IN OVO SELENIUM INJECTION ON CHICK 
EMBRYO VIABILITY AND TISSUE SELENIUM 
CONCENTRATIONS 
 
INTRODUCTION 
Selenium (Se) has been shown to be an essential trace mineral in poultry   
nutrition.  Thus, a dietary Se deficiency in poultry can lead to symptoms such as 
exudative diathesis (Scott et al., 1957; Schwarz et al., 1957; Patterson et al., 1957; 
Noguchi et al., 1973), pancreatic fibrosis (Thompson and Scott, 1969; Gries and Scott 
1972), gizzard and heart myopathies in turkeys (Scott et al., 1967; Cantor et al., 1982b), 
reduced fertility (Combs, 1994), reduced hatchability as well as reduced egg production 
(Latshaw and Osman, 1974; Cantor and Scott, 1974). When dietary Se is supplemented to 
hen diets, it can increase the transfer of Se to eggs (Cantor et al., 2000) and consequently 
to the embryo (Paton et al., 2002), and thus potentially prevent conditions associated with 
selenium deficiency. 
Previous studies have also shown that Se injected into the egg is potentially toxic 
to chick embryos. Franke et al. (1936) reported lethal doses for 50% (LD50) of embryos 
of 35 µg Se as selenite injected into air cell of eggs before incubation. This dose also led 
to a high incidence of embryo abnormalities. Ridgway and Karnofsky (1952) found an 
LD50 of 20 µg Se /egg as selenite when injected via the yolk sac at d 4 and 8 of 
incubation. Halverson et al. (1965) performed an air cell injection of selenite at d 14 of 
incubation and reported an LD50 of 25 µg Se/egg. Palmer et al. (1973) injected fertile 
eggs with Se via the air cell at d 4 of incubation and found that Se-Met was more toxic 
than selenite, with Se-Met having an LD50 of 6.5 µg/egg compared with selenite with an 
LD50 of 15 µg Se/egg. Sukra et al. (1976) also used selenite in a chick embryo study and 
reported an even lower LD50 of 1.5 µg Se/egg when injected via the air cell at d 3, 5, 9 
and 15 of incubation. 
The goals of this experiment were 1) to determine if using in ovo injection at 10d 
of incubation could enhance se status of the embryo 2) if Se could safely be injected and 
3) if Se-Met or Na2SeO3 were metabolized differently by the embryo. Therefore the 
current study was undertaken to investigate the effects of injecting graded level of Se as 
Se-Met or Na2SeO3 on embryo viability and tissue selenium concentrations. 
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MATERIALS AND METHODS 
Preliminary Research Study 
Site and Time of Injection 
There are different sites in which an avian egg can be injected through the 
eggshell to gain access to the embryo, including the air cell, the yolk sac, the extra-
embryonic coelom, and the amnion. However, previous Se injection studies showed two 
of these four sites were most commonly used, i.e., the yolk sac and air cell. However, 
since during embryonic development, yolk is the primary source of energy and nutrients 
including selenium, i.e., until the digestive tract is functional, the yolk sac was the most 
logical route to use for this study. In addition, Ohta et al. (2001) showed that the yolk and 
the extra embryonic coelom were the best injection site for nutrients such as amino acids. 
Paton et al. (2002) demonstrated that the greatest increase in Se concentration in the 
chick embryo occurred between 10-15 days of incubation. From a practical standpoint, 
the outline of the yolk at 10 d of incubation is large enough to seen through the shell 
during candling, in addition, identifying the embryo becomes easier then. 
Location of the Yolk 
 To deliver the nutritive solution into the yolk by injection without the risk of 
hitting the embryo or any major blood vessel it was necessary to candle each egg to 
locate the embryo, which appeared as a dark floating silhouette and the head as a dark 
spot. Usually under the candling light, healthy embryos move in response to the light. 
However, there are some embryos that tend to be sluggish and take a little bit more time 
to start moving. The egg was turned about a quarter turn away from the head, to locate 
the yolk, the target site of injection. 
 
Preliminary Research Study - Verification of Injection Procedure 
One of the most critical point in this experiment was to determine that yolk was 
the site where the solution is being delivered. Therefore to, ascertain this, a food grade 
blue dye diluted in PBS was injected into the yolk of 85 fertile eggs after 10 days of 
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incubation. Sterile water and PBS were also included as injection control solutions, using 
15 eggs for each. The blunt end of the egg was held under the candler and the position of 
the embryo as well as the yolk was determined as described above. The outline of the air 
cell was traced around the shell and a small hole was drilled onto the egg shell. Eggs 
were injected with 0.5ml food grade dye in PBS, sterile water or PBS alone. Holes were 
sealed using glue and eggs were then returned to the incubator. At Day 18 of incubation, 
eggs were candled prior to transfer to the hatcher. At the same time, five eggs from the 
dye-injected group were sampled for inspection of the correctness of injection site.  
Day of Hatch 
 At day of hatch, baskets containing the chicks were pulled out of the incubator 
and the numbers of chicks alive and dead were recorded. 
Study 1 - In Ovo Injection of Graded Levels of Se  
This experiment was conducted at the University of Kentucky Poultry Farm. All 
procedures were conducted under protocols approved by the Institutional Animal Care 
and Use Committee (IACUC). Fertile white eggs from Hy-Line W-36 hens (Hy-Line 
International, IA) fed a low-Se diet were used for this study. Fertile eggs were incubated 
at 37.5°C and a relative humidity of 55 to 60% during d 1-18 and at 36 °C with relative 
humidity of 60-65% during d 19-21. Two sources of Se, Se-Met and Na2SeO3, were used 
at five injection doses each (0, 2.5, 5, 10 or 20 µg Se/egg).  At least 30 eggs were allotted 
to each injection treatment. Sham-control eggs injected with phosphate buffered saline 
(PBS) and non-injected eggs were also included. Average egg weight was approximately 
50 g. 
Preparation of Se Solutions 
Sterile phosphate buffered saline (PBS) was prepared with Sigma® PBS tablets 
(Sigma®, St. Louis, MO) (10 mM phosphate buffer, 2.7 mM KCl, 137 mM NaCl, pH 
7.4) according to manufacturer’s instructions and was autoclaved at 121°C for 45 min. 
Seleno-L-methionine (Sigma®) or Na2SeO3 (Sigma®) was dissolved in PBS to make a 
200 µg Se/ml stock solution which was subsequently diluted with PBS to make 
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solutions containing 100, 50 and 25 µg Se/ml. All solutions were filtered using a 0.22 µ 
acetate/pre filter (MSI®, Westborough,MA). 
Se Injection  
At d 10 of incubation, eggs were removed from the incubator and candled for 
viability. Under the candler, the outline of the air cell was traced using a pencil and the 
location of the embryo marked. After disinfecting the shell with an alcohol swab, a small 
hole was drilled on the larger end of the egg, above the air cell. Using a 23 gauge, 1 ½” 
(0.6mm x 40mm) needle, 0.1 ml of the Se solution was injected into the yolks to provide 
doses of 20, 10, 5, 2.5 and 0 µg Se. The injection site on the shell was sealed with glue 
and eggs were returned to the incubator.  
Tissue Sample Collection 
After 20 d of incubation eggs were removed from the incubator and the embryos 
were euthanized through cervical dislocation for liver, lung and heart tissue collection. 
For each treatment group, three pooled samples of 10 tissues were collected.  Samples 
were frozen at -20°C until analysis. 
Analytical Procedures 
Liver, lung and heart samples were analyzed for Se content according to the 
fluorometric assay following nitric-perchloric acid digestion described by Olson et al. 
(1975) with modifications by Cantor and Tarino (1982).   
Statistical Analyses 
Results were analyzed using the general linear model for ANOVA procedures, 
there was a factorial arrangement of treatments using two Se sources and 5 injection 
doses. Se source x dose treatment means were separated by the test of least significance 
difference (LSD). Linear regression was performed to analyze the relationship between 
tissue Se concentration in response to the doses injected (Statistix 9.0). Comparison of 
slope was performed to test the difference between the two regression lines. 
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RESULTS AND DISCUSSION 
Preliminary Research Study 
For the preliminary study, Figure 3.1,A, depicts the location of the embryo in 
relation to where the yolk was located. At day 18 of incubation, upon opening the five 
eggs injected with blue dye, it was noted that color of the yolks had a greenish tinge 
compare with the normal yellow color of uninjected eggs (Figure 3.1,B), probably the 
combination of yellow yolk and blue food grade dye that was injected. At day of hatch, 
the newly hatched chicks also possessed bluish tinged-down. Viability is shown in Table 
3.1. The dye injected fertile eggs had 91% viability, which wad similar to the values for 
PBS or water injected fertile eggs with 93%.  The preliminary results indicated that the 
injection technique had minimal effect on embryo viability and mortality attributed to 
injection trauma was very limited.  Therefore, the subsequent research study on in ovo 
injection of Se could be carried out using the procedures of the preliminary trial. 
Study 1 – In Ovo Injection of Graded Levels of Se  
The effects of graded doses (0, 2.5, 5, 10 and 20 µg/egg) of Se either Se-Met or 
Na2SeO3 injection on embryo viability 10 d post-Se injection is summarized in Table 3.2. 
Embryo viability ranged from 84 to 97% for eggs injected with graded doses of Se-Met 
and from 74 to 94% for those injected with Na2SeO3. The viability of embryos for PBS-
injected and the non-injected eggs was 90 and 100%, respectively.  The Se-Met-injected 
eggs had higher embryo viability (percentage of live embryos of injected eggs) compared 
with the Na2SeO3 group. Upon opening each egg, the presence of any signs of 
abnormalities, such as inflammation of the neck and head region, as well as beak, leg and 
toe deformities (Franke et al., 1936), were noted and embryo deaths were recorded. For 
this study, neither the injection of Se-Met nor the Na2SeO3 produced any untoward 
abnormalities in the embryo, in contrast to reports from previous Se injection studies.  
Our finding may indicate that both Se sources up to 20 µg Se/egg (based on 50-g egg 
weight) did not affect the development of the embryo enough to produce abnormal 
growth.
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The LD50 of Se injected in chicken eggs at 9 d of incubation has been reported as 
approximately 0.030 ppm when given via the air cell (Sukra et. al., 1976). In contrast, 
when injected via the yolk sac at 8 d of incubation, investigators found the LD50 to be 0.4 
ppm (20 µg/egg) (Ridgway and Karnofsky, 1952) and between 0.01 to 0.025 mg/egg (18 
µg/egg) when administered at 4 d of incubation (Kury et al., 1973). Survival rate in the 
Ridgway and Karnofsky (1952) study was 10-20% compared with 28% livability (or 72% 
mortality) in the study by Kury et al. (1967). In a study by Palmer et al. (1973), the 
toxicity of Se as Se-Met was similar to that as selenate (LD50 = 0.13 µg/ml or 5.46 
µg/egg), but greater than that as selenite (LD50 = 0.3 µg/ml or 12.6 µg/egg). They found 
that the ratio of live chicks to total fertile eggs injected decreased from 16/17 to 2/18 
when the injected Se concentration increased from 0.1 to 0.4 ppm. However, in the 
current study, we observed that injecting up to 20 µg Se/egg did not negatively affect 
embryo viability and, therefore, was not found to be a toxic dose. 
The overall effect of Se in ovo injection on liver, lung and heart muscle Se 
concentrations is shown on Table 3.3A. Regardless of Se source, the Se content of the 
liver was higher than that of the lung and heart muscle. This result is consistent with 
previously reported studies on Se distribution and retention in the liver (Leeson et al., 
2008; Pan et al., 2007; Payne and Southern, 2005).  
 Selenium concentrations in the liver linearly increased with graded levels of Se 
injected for both the Na2SeO3 and Se-Met (Figure 3.2). However, the regression 
coefficient (Table 3.3B) was significantly greater for Na2SeO3 than for Se-Met (0.06 vs 
0.01). 
The effect of Se injections also resulted in linear increases in tissue Se in lung, 
except resulting concentrations were lower compared with liver. For example, injecting 
20 µg Se as Na2SeO3 resulted in a Se concentration of 1.517 µg/g in liver but only 0.664 
in lung (wet basis) (Figure 3.3). The regression coefficient for the Na2SeO3 was 
significantly higher than that for Se-Met (P < 0.001) (0.02 for Na2SeO3 vs 0.01 for Se-
Met). Figure 3.4 depicts the effect of Se injection on the heart muscle. 
Linear increases for tissue Se concentrations were observed in this experiment 
however Na2SeO3 was higher than Se-Met. These result were also demonstrated by 
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Noguchi et al. (1973) wherein at low Se concentration, Na2SeO3 was slightly effective in 
stimulating plasma GSH-Px activity than Se-Met.   
Omaye and Tappel (1974) also showed this dose-response relationship in 20-24 d 
old chicks, that at low Se concentrations, the liver and the heart soluble fractions had 
slightly higher mean GSH-Px activities than Se-Met. On the other hand, Cary et al. 
(1973) concluded that dietary Se levels given at less than 0.1 ppm in weanling rats 
showed no difference in tissue Se retention between Na2SeO3 and Se-Met. Consequently 
when dietary supplementation was more than 0.1 ppm, tissue Se retention was higher for 
Se-Met than Na2SeO3. This is parallel to the pig study conducted by Mahan and Parrett 
(1996), where diets were supplemented with 0.1, 0.3 or 0.5 ppm Se as Na2SeO3 or Se-
enriched yeast. These authors demonstrated that, at dietary level of 0.1 ppm, serum Se 
concentration was higher for Na2SeO3 than Se-enriched yeast and this resulted in an 
interaction response between these two variables (P < 0.01).  On the contrary, Whanger 
and Butler (1988), rats fed with different levels of Se (0.2, 1.0, 2, or 4 mg/kg), and it 
revealed that at a level of 0.2 ppm tissue Se concentration did not differ between Se-Met 
and Na2SeO3.  However, when Se supplementation was increased, Se-Met tissues 
expressed higher accumulation of Se-Met than Na2SeO3.  
In contrast to previously reported Se-injection studies, our study demonstrates for 
the first time that injecting white shelled fertile eggs after 10 d of incubation via the yolk 
sac with doses up to 20 µg Se does not adversely affect embryo viability. These unique 
observations could probably be attributed to the route of injection and the day of 
incubation when the eggs were injected. Furthermore, liver and lung, but not heart, Se 
concentrations were found to be higher in response to Na2SeO3 than Se-Met from tissues 
harvested at 20 d of incubation. The effects of the Se-Met and Na2SeO3 on liver and lung 
Se concentrations suggest that these compounds are metabolized differently by the chick 
embryo.
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    A      B 
 
   Figure 3.1. Yolk sac injection at d10 of incubation and presence of blue dye                 
A) Schematic diagram showing injection site in the yolk B) Photograph showing 
the presence of blue dye in the yolk after Day 18 of incubation. 
 
     
 
 
 
 
Table 3.1. Results of preliminary in ovo blue dye injection study.    
                 Number of Live embryos 
 
Injection Solution Day 10        Day 18        Day 21            Viability, %** 
Blue Dye       85          80* 77  91 
Water 15        15 14 93 
PBS 15        14 14 93 
n= the number of live embryos at Day 10 
*5 eggs were sampled  at d 18, 4 alive, 1 dead 
** Viability = (live embryos at d 21÷ Live embryos at d 10)* 100 
Yolk 
Embryo 
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Table 3.2.  Se injection and embryo viability (%) at 20 days of incubation.* 
 
 
Dose, µg/egg Se-Met 
 
Na2SeO3 
 
 
0 
 
93.7 
 
93.7 
 
2.5 
 
96.7 
 
87.0 
 
5.0 
 
93.7 
 
93.7 
 
10 
 
90.0 
 
74.0 
 
20 
 
83.0 
 
87.0 
 
*Viability = (live embryos at d 21÷ Live embryos at d 10)* 100 
 
Table 3.3A. Effect of Se in ovo injection on embryonic tissues at 20 d of incubation. 
 
 
Se Source 
 
Na2SeO3    Se-Met  Na2SeO3    Se-Met  Na2SeO3    Se-Met  
      Dose Liver Lung Heart 
0 0.348f  0.358ef 0.202d 0.208d 0.315a 0.300a 
2.5   0.453def   0.418def 0.219d  0.268cd 0.252b 0.240b 
5 0.516d  0.502de  0.246cd  0.274cd 0.238b 0.200c 
10 0.808b 0.524d  0.251cd 0.403b 0.252b 0.240b 
20 1.518a 0.664c 0.304c 0.538a 0.315a 0.300a 
SEM 0.151  0.036  0.042     0.012 0.014   0.013 
 
P value 
Source 0.000 0.0003 0.071 
Dose 0.000 0.000 0.000 
Source*Dose 0.000 0.005 0.379 
a-f :  P < 0.05 
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      Table 3.3B. Comparison of slope for tissue Se concentration (μg/g) of embryos at 20 d of   
                 incubation. 
 
 
Tissue 
 
         Se Source 
 
Slope 
 
P value 
 
 
Liver 
 
Na2SeO3 
 
0.06  < 0.001          Se-Met 0.01 
 
Lung Na2SeO3 0.02 
 < 0.001          Se-Met 0.01 
 
Heart Na2SeO3 0.01 
0.772           Se-Met 
 
0.01 
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Figure 3.3. Lung Se concentration (wet basis, μg/g) of  20-day-old embryo 
injected with Se containing 0, 2.5, 5, 10 or 20 μg Se as Se-Met or 
Na2SeO3.  
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Figure 3.2. Liver Se concentration (wet basis, μg/g)) of 20-day-old embryo 
injected with Se containing 0, 2.5, 5, 10 or 20 μg Se as Se-Met or 
Na2SeO3.  
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Figure 3.4. Heart Se concentration (wet basis, μg/g) of 20-day-old embryo 
injected with Se containing 0, 2.5, 5, 10 or 20 μg Se as Se-Met or 
Na2SeO3.  
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CHAPTER 4: TOXICITY AND TISSUE SELENIUM LEVELS OF CHICKEN 
EMBRYOS RESULTING FROM IN OVO SELENIUM INJECTION  
 
 
INTRODUCTION 
Although Se has been shown in many previous studies to be essential in 
embryonic development of various poultry species (Thompson and Scott, 1970, Scott et 
al., 1967, Cantor and Scott, 1974, Cantor et al., 1982) it has also been reported to be toxic 
to developing embryos at high levels whether injected in ovo (Sukra et al, 1976; Palmer 
et al., 1973; Kury et al., 1967; Halverson et al., 1965; Franke et al., 1936; Ridgway and 
Karnofsky, 1952) or supplemented to hen diets (Heinz and Hoffman, 1996; Ort and 
Latshaw, 1978) 
In a previous experiment, we tested the effect of Se injected into the yolk sac 
incubating eggs after 10 d of incubation. From that study, we concluded that Se either as 
Se-Met or Na2SeO3 up to 20 µg/egg was not detrimental to the developing embryo. In 
addition, no physical abnormalities or deformities were noted on embryos as has been 
reported by previous investigators.  Linear increases in total tissue Se concentration were 
evident as the dose of Se injected increased.  Liver and lung Se concentrations were 
significantly higher for eggs injected with Na2SeO3 than Se-Met, but did not differ for Se 
concentrations in heart tissue.  
Based on these results, the present study was conducted to determine the effect of 
high doses of Se (up to 60 µg/egg) injected in 10-d-old fertile eggs via the yolk sac on 
livability, and tissue Se concentration. 
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MATERIALS AND METHODS 
 
Experimental Animals and Treatments 
This experiment was conducted at the Alltech-University of Kentucky Research 
Alliance Poultry Farm. All procedures for this study were conducted under protocols 
approved by the University of Kentucky Institutional Care and Use Committee (IACUC). 
Fertile white shelled eggs from Hy-Line W-36 hens (Hy-line® International, IA) were 
incubated at 37.5°C and at a relative humidity of 55 to 60% during d 1-18 and at 36.9 °C 
with relative humidity of 60-65% during d 19-20. There were two sources of Se Se-Met 
and Na2SeO3 were used at three Se injection doses (20, 40 and 60 µg Se/egg).  At least 25 
eggs with four replications were equally allotted to the three Se treatment doses for Se-
Met and Na2SeO3. Sham controls were also included which were injected with PBS.  
Average egg weight was approximately 50 g. 
Preparation of Se Solutions 
 Sterile PBS was prepared with PBS tablets (Sigma®, St. Louis, MO)  (10 mM 
phosphate buffer, 2.7 mM KCl, 137 mM NaCl, pH 7.4) according to manufacturer’s 
instructions and was autoclaved at 121°C for 45 min. Seleno-L-methionine (Sigma®) or 
Na2SeO3 (Sigma®) was dissolved in PBS to make a 100 µg Se solution which was 
subsequently diluted with PBS to make 60, 40 and 20  µg Se solutions. All solutions were 
filtered using a 0.22 µ acetate/pre filter (MSI®, Westborough, MA). 
Se Injection Procedure 
At d 10 of incubation, eggs were removed from the incubator, candled for 
viability and prepared for Se injection. Under a candler, the outline of the air cell was 
traced using a pencil and the location of the embryo marked. After disinfecting the egg 
shell with alcohol swab, a small hole was drilled on the larger end of the egg, above the 
air cell. Using a disposable tuberculin syringe with a 23 gauge, 1 ½” (0.6 mm x 40 mm) 
needle, 0.1 ml of the appropriate Se solution was injected into the yolk. The injection site
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on the eggshell was sealed with glue and eggs were returned to the incubator with 
settings according to standard hatchery practices. 
Embryo Livability  
After 18 d of incubation, eggs were candled and any dead embryos were counted 
and then discarded. By the end of the study, at 20 d of incubation, all eggs were broken 
out and visually inspected for signs of physical abnormalities. The number of dead 
embryos was recorded. The livability (%) was calculated as the number of embryos that 
were alive on d 20 divided by the number of eggs that were injected on d 10 of incubation 
multiplied by 100. 
Tissue Sample Collection 
After 20 d of incubation, embryos were euthanized by cervical dislocation. Two 
samples of liver, lung, heart and breast muscle were pooled from 5 embryo per source x 
dose treatment and frozen at -20°C until analysis. 
Analytical Procedures 
Liver, lung, heart and breast muscle samples were analyzed for Se concentration 
according to the fluorometric assay of Olson et al. (1975) with modifications by Cantor 
and Tarino (1982). Within each pooled sample, tissues were minced and manually 
macerated to make each replicate a more homogeneous sample.  Macerated tissues were 
weighed into digestion tubes and digested in nitric and perchloric acids. The Se 
concentration of liver, lungs, heart and breast muscle was calculated for each Se source 
and dose by d 20 of incubation. 
Statistical Analyses 
Results were analyzed by ANOVA. Se source x dose treatment means were 
separated by the test of least significance difference (LSD). Linear regression analysis 
was used to compare the relationship between tissue Se concentrations to Se-Met- and 
Na2SeO3 injection doses (Statistix 9.0). Comparison of slope was performed to test the 
difference between the two regression lines.
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RESULTS AND DISCUSSION 
 
The effect of injecting graded levels of Se at 20, 40 and 60 µg/egg either as Se-
Met or Na2SeO3 did not produce any physical deformities in embryos by d 18 and 20 of 
incubation, as shown in Table 4.1. At the 60 µg Se dose, % livability was higher (P < 
0.05) for embryos injected with Se-Met compared with Na2SeO3 . 
The concentration of selenium in tissues is affected by several factors such as the 
dietary Se concentrations, number of days Se is consumed, the form or source of Se, 
whether organic or inorganic in nature, and the type of tissue. Animals in utero, or in the 
case of birds, in ovo, Se levels would be highly dependent on the Se level of the maternal 
diet (Paton et al., 2002; Surai, 2000; Cantor and Scott, 1974; Latshaw and Osman, 1974).  
Tissue Se concentrations corresponding to each Se source and dose used are 
presented in Table 4.2. The order of Se concentration in d 20 embryo tissues was liver > 
lung > heart > breast regardless of Se source. Injecting graded doses of Se as Se-Met or 
Na2SeO3 into the yolk sac of 10-d-old incubating eggs resulted in significant linear 
increases in the Se concentrations for all of the tissues collected in this study (P < 0.05).   
The Se levels of liver and lungs at 20 d of incubation are presented in Figures 4.1 
and 4.2. In response to either Se-Met and Na2SeO3, the pattern of Se concentrations in 
liver was similar to that in the lung. The liver Se concentrations increased linearly with 
increasing Se dose using either Se-Met or Na2SeO3 (Figure 4.1). However, the liver Se 
concentrations in response to 60 µg Se as Na2SeO3 did not differ from the response to 40 
µg Se as Se-Met (2.474 vs 2.049, μg/g). Although both Se sources increased liver Se, the 
regression coefficient (Table 4.3) for Se-Met was significantly higher than the regression 
coefficient for Na2SeO3 (0.49 vs. 0.80). Although, the lung tissue followed the same trend 
as liver, Se concentrations were about one third of those in the liver. Again at 60 µg, 
Na2SeO3 did not differ from the 40 µg SeMet (P < 0.05). These results are similar to 
those of previous studies (Surai, 1999; Gaál et al., 1995) wherein glutathione peroxidase 
(GSH-Px) expression in the liver of the developing embryo was higher than in the lungs. 
Selenium is a critical component of GSH-Px, which participates in antioxidant defense in 
the liver, helping to prevent lipid peroxidation (Rotruck et al., 1973). Thus, providing 
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high levels of Se in ovo may be beneficial during embryonic development to prevent 
possible embryotoxicans present at the time of hatching and onwards. Linear increases in 
the Se concentration in the heart and breast muscle are shown in Figures 4.3 and 4.4. Se-
Met injection resulted in significantly greater accumulation of Se in both tissues 
compared with Na2SeO3. In the breast muscle, regression coefficient for Se-Met was 0.33 
compared with 0.06 for Na2SeO3 (P < 0.0001). In response to Na2SeO3, the pattern of Se 
concentrations in the heart was comparable to that observed in breast muscle, i.e., tissue 
concentrations did not differ in response to the 40 and 60 µg doses (Table 4.3). These 
tissue levels were similar to those in response to 40 µg Se as Se-Met. Increasing the Se 
doses from 40 to 60 µg Se as Na2SeO3 did not significantly increase the Se concentration 
in heart nor in breast muscle (P > 0.05). The respective Se concentrations obtained at 
doses of 40 and 60 µg, were 0.508 and 0.513 µg/g for the heart and 0.326 and 0.361 µg/g 
for breast muscle. Regression coefficients for Na2SeO3 and Se-Met in breast tissue were 
0.06 and 0.33, respectively (Table 4.3). These findings were similar to those of previous 
studies, wherein Se concentration in tissue in response to Se-Met continuously increased 
with increasing Se dose, whereas Se concentrations in tissue in response to Na2SeO3 dose 
eventually leveled off. This result was similar to the effect of dietary Na2SeO3 on Se 
concentrations of whole egg and egg fractions when various levels of dietary Se (0.1-0.3 
mg Se/kg feed) were added fed to white laying hen (Paton et al., 2002). Egg Se 
concentrations reached a plateau at dietary levels of 0.2 mg Se/kg feed Se when Na2SeO3 
was added to the diet but continued to increase when Se yeast was fed. 
The observations in the current experiment were similar with those of Cary et al, 
(1973) and Scott and Thompson (1971). The differences observed in Se metabolism and 
tissue concentration as been explained as follows. Selenium as Na2SeO3 in excess of 
amount equivalent to certain binding sites maybe eliminated from the body whereas 
seleno-amino acids in excess of the primary binding sites may be incorporated into 
proteins. It is known that Se-Met replaces methionine during protein synthesis, which 
results in Se incorporation into tissue proteins. Due to the exponential growth and 
development of the embryo as it reaches the time of hatching, the rate of protein synthesis  
is high, thereby allowing for greater Se accumulation as Se-Met.  
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In ovo injection of Se up to 60 µg/egg did not prove to be toxic to the developing 
embryo, since this dose did not produce physical abnormalities or increased mortality. 
Although both Se sources linearly increased the Se levels in embryonic tissue, 
concentrations in response to Se-Met increased continuously, whereas Se retention in 
response to Na2SeO3 leveled off at the 40 µg dose.  
  64 
Table 4.1. Embryo livability (%) at day 18 and 20 of incubation.1 
 
Treatment Se Source Se Dose  µg Se/egg 
                 Livability (%)1,2 
 
           Day 18               Day 20             
 
1 PBS 0 96ab 95ab 
2 Na2SeO3 20 88b 86b 
3 Na2SeO3 40 87b 84b 
4 Na2SeO3 60 84b 82b 
5 Se-Met 20 96ab 93ab 
6 Se-Met 40 92ab   87abc 
7 Se-Met 60 100a  97a 
SEM   1.61 1.57 
1Livability = Live embryos at d18 or 20 ÷ live embryos at d 10)*100 
a-c : P < 0.05. 
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Table 4.2 Embryonic tissue Se concentration  (wet basis, µg /g) at 20 days of    
            incubation. 
 a-f : P < 0.05. 
 
 
 
Table 4.3. Comparison of slope for liver, lung, heart and breast muscle Se concentration at 
20 days of incubation. 
 
 
Tissue 
 
Se Source 
 
N 
 
Slope 
 
P value 
 
 
Liver 
 
Na2SeO3 
 
12 
 
0.49 0.0032  Se-Met 12 0.80 
 
Lung Na2SeO3 12 0.20 
0.0006  Se-Met 12 0.30 
 
Heart Na2SeO3 12 0.06 0.0000 
  Se-Met  
12 0.31 
Breast Na2SeO3 11 0.06 P < 0.001 
 Se-Met 12 0.33 
 
Se Source Dose 
μg Se/egg 
Liver Se 
μg/g  
Lung Se 
μg/g 
Heart Se 
μg/g 
Breast Se 
 μg/g 
PBS 0 0.621e 0.261f 0.227f 0.163f 
Na2SeO3 20 1.426d 0.459e 0.384e 0.247e 
Na2SeO3 40 2.049c 0.710c 0.508d 0.326d 
Na2SeO3 60 2.412b 0.855b 0.513c 0.361d 
Se-Met 20 1.620cd 0.557e 0.556c 0.484c 
Se-Met 40 2.474b 0.866b 0.846b 0.745b 
Se-Met 60 3.221a 1.184a 1.184b 1.141a 
SEM 0.117 0.023 0.019 0.022 
                                              P value 
      
Source 
Dose 
Source*Dose 
 
0.0001 
0.0000 
0.0000 
 
0.0000 
0.0000 
0.0000 
 
0.0000 
0.0000 
      0.0000 
 
0.0000 
0.0000 
0.0000 
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 Figure 4.1. Liver Se concentration (wet basis, µg /g) of embryo at day 20 of   
                            incubation. 
                              
 
 
 
           Figure 4.2. Lung Se concentration (wet basis, µg /g) of embryo at day 20 of  
                          incubation.       
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       Figure 4.3. Heart Se concentration (wet basis, µg /g) of embryo at day 20 of  
                       incubation. 
                         
 
 
     Figure 4.4. Breast Se concentration (wet basis, µg /g) of embryo at day 20 of  
                    incubation 
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CHAPTER 5: EFFECT OF IN OVO SE INJECTION OF BROILER BREEDER 
EGGS AT 10 DAYS OF INCUBATION ON TISSUE SE 
CONCENTRATION AND EMBRYO VIABILITY 
 
INTRODUCTION 
The essentiality of Se in the hen diet has been documented for the growth and 
development of the chick and turkey embryo (Thompson and Scott, 1970; Scott et al. 
1967; Cantor and Scott, 1974). Dietary addition of Se has shown that it can be transferred 
to the yolk, embryo and eventually to the embryonic tissues (Paton et al., 2002, Surai, 
2000, Pappas et al., 2005, 2006).  Many nutrient deficiency symptoms seen in young 
chicks also occur during embryonic development. For example, feeding Se-vitamin E 
deficient diet to turkey breeder hens resulted in well developed gizzard myopathy in 
newly hatched poults, indicating that deficiency lesions developed during embryonic 
growth (Cantor et al., 1978).  
 The amount of Se that can be added to breeder diets is limited by the United 
States Food and Drug Administration (FDA) to 0.3 mg/kg. Hence, the amount of Se that 
can be transferred from the hen to the egg is thereby limited. A way to offset this 
limitation is through early embryo manipulation by injecting Se into the yolk of 
incubating eggs. This can elevate the levels of Se in the embryo via the yolk.  During 
embryonic development the yolk is the major source of energy and nutrients including Se. 
It has been reported that yolks from hens fed a low Se diet supplemented with 0.3 ppm Se 
contained 6-7μg Se (Paton et al., 2002). From these previously mentioned literature Se is 
deemed essential to the diet not only for the breeders but in the embryo as well.  However, 
earlier investigations on Se injection on the literature resulted in high embryo mortality 
and embryos that showed physical developmental defects (Sukra et al., 1976; Palmer et 
al., 1973, Kury et al., 1967; Halverson et al., 1965; Franke et al., 1936; Ridgway and 
Karnofsky, 1952). It was reported that the LD 50 for selenite when injected through the 
yolk sac ranged from 18-20 µg Se/egg via the yolk sac and 1.5-35 µg Se/egg via the air 
cell. On the other hand the LD50 for Se-Met was found to be 6.5 µg Se/egg via the air 
cell. In our laboratory, we have conducted studies on injecting Se into the yolk of 10-day-
old fertile white layer eggs. Based on the results of our first study, we have shown that 
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injecting graded doses i.e., 0, 2.5, 5.0 10 and 20 μg Se either as Se-Met or Na2SeO3 did 
not produce any developmental abnormalities and low embryo mortality was observed at 
d 20 of incubation (Macalintal et al., 2010a). Linear increases on tissue Se accumulation 
resulting from injecting both Na2SeO3 and Se-Met were observed. In our second study, 
we increased the Se injection dose up to 60 μg Se/egg, and it was determined that 
injecting up to 60 μg Se did not negatively affect embryo viability (Macalintal et al., 
2010b). Linear increases in tissue Se were also observed as the injection doses increases, 
similar to the low dose injection study.  
These aforementioned studies in our laboratory were conducted in Leghorn eggs, 
thus, the current study was undertaken to verify these results using broiler eggs. 
Improved tissue Se levels at hatching may help broilers overcome environmental stresses 
and disease challenges associated with method of rearing. Therefore, the aim of this study 
is to investigate the effects of injecting Se up to 40 μg Se into the yolk of 10-day-old 
incubating broiler eggs on tissue Se concentration and embryo toxicity. 
MATERIALS AND METHODS 
Experimental Animals and Treatment Groups 
This experiment was conducted at the Alltech-University of Kentucky Research 
Alliance Poultry Farm facilities. All procedures were conducted under protocols 
approved by the Institutional Animal Care and Use Committee (IACUC). Six hundred 
(600) Cobb® 500 fertile brown eggs obtained from Cobb-Vantress, Monticello, KY were 
used for this study. Fertile eggs were incubated at 37.5°C and a relative humidity of 55 to 
60% during d 1-18 and at 36.9°C with relative humidity of 60-65% during d 19-21. Two 
sources of Se, Se-Met and Na2Seo3 and six Se doses were used (0, 2.5, 5, 10, 20 and 
40µg/egg) to inject the eggs.  At least thirty (30) eggs were allotted to each injection 
treatments. Sham control eggs injected with phosphate buffered saline (PBS). All 
solutions were prepared in sterile PBS solution.  Total weight of egg contents was 
approximately 40g. 
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Preparation of Se Solutions 
Phosphate buffer saline (PBS) was prepared with Sigma® (Sigma, St. Louis, MO) 
PBS tablets (10mM phosphate buffer, 2.7 mM KCl, 137 mM NaCl, pH 7.4) according to 
manufacturer’s instructions and was autoclaved at 121°C for 45 min. Se-Met (Sigma®) 
or Na2SeO3 (Sigma®) was dissolved in PBS to make up a 600 µg Se /ml Se solution 
which was subsequently diluted with PBS to make up 400, 200,100, 50 and 25 µg Se/ml 
solutions. All solutions were filtered using a 0.22µ acetate/pre filter (MSI®, Westborough, 
MA). 
Se Injection Procedures 
At d 10 of incubation, eggs were removed from the incubator and candled for 
viability. Under the candler, the outline of the air cell was traced using a pencil and the 
location of the embryo marked. After disinfecting the eggshell with an alcohol swab, a 
small hole was drilled on the larger end of the egg, above the air cell. Using a disposable 
tuberculin syringe with a 23 gauge, 1 ½” (0.6mm x 90 mm) needle, 0.1ml of the 
appropriate Se solution was injected into the yolk. The injection site on the eggshell was 
sealed with glue and eggs were returned to the incubator with settings according to 
standard hatchery practices. 
Transfer to Hatcher at Day 18 
At day 18 of incubation eggs were carefully candled for viability prior to transfer 
to the hatcher. 
Day 20 Tissue Sample Collection 
At 20 d of incubation, eggs were removed from the incubator and cracked open 
for liver, lung, heart and breast muscle tissue collection. Five pooled samples of each 
tissue were collected per Se treatment. Samples were frozen at -20°C until analysis. 
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Analytical Procedures 
Liver, lung and heart samples were analyzed for Se content according to 
fluorometric assay by Olson et al. (1975) with modifications by Cantor and Tarino (1982).  
Three pooled samples of 5 tissues were used per treatment group.  
Statistical Analyses 
Results were analyzed by ANOVA and Se source x dose treatment means were 
separated by the test of least significance (LSD). Linear regression analysis was used to 
compare the linear response between the tissue Se concentration and doses injected into 
the eggs using either Se-Met or Na2SeO3 (Statistix 9.0). Comparison of slope was 
performed to test the difference between the two regression lines. 
 
RESULTS AND DISCUSSION 
Injecting 10 d old broiler eggs via the yolk sac with graded levels of Se either as 
Na2SeO3 or Se-Met resulted in low embryo mortality. No abnormalities such as head and 
neck enlargement nor leg and toe malformations were observed when incubating eggs 
were injected with doses up to 40 µg Se/egg at 18 and 20 days of incubation. These were 
comparable with the results from our pervious leghorn eggs studies. These observations 
were in contrast to earlier reports which suggested that injecting Se into fertile eggs 
resulted to high mortality and embryos with physical abnormalities such as craniofacial 
deformities, and limb reduction (Franke et al., 1936, Halverson et al., 1965; Palmer et al, 
1973). The probable difference in our results could be due to the following reasons; route 
of administration, time of injection, quality of solutions used and quality of injection 
procedures.  
 The effects of in ovo Se injection on livability are shown on Tables 5.1 and 
5.2. At d 18 and 20 (Table 5.1), livability was not affected by source nor source x dose 
interaction but it was significantly affected by dose. At d 18 of incubation, embryo 
livability for Na2SeO3 and Se-Met injected eggs ranged from 98-78 and 100-78% 
respectively. In Table 5.2, the significant effect on dose at d 18 indicated that eggs 
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injected above 20 µg Se/egg resulted to lesser embryo survival than eggs injected with 
less than 20 µg Se/egg. On the other hand, injecting more than 10 µg Se/ egg decreased 
livability at d 20 of incubation. Livability may be decreased but it was not enough to 
produce embryonic abnormalities as previously described.  
Linear increases for tissue Se concentrations were observed, as a result of 
injecting graded levels of Se (P < 0.01) either as Na2SeO3 or Se-Met. However, linear 
responses behaved differently for the two Se sources for the liver, lung, heart and breast 
muscle. The order of tissue Se concentration for this investigation was liver > lungs > 
breast = heart, which is comparable with previous studies (Surai et al., 2006, Apsite and 
Atlavin, 1994, Omaye and Tappel, 1974).  
Higher tissue Se accumulation was observed with Se-Met than when Na2SeO3 was 
injected. In addition, the regression coefficients for tissue Se concentrations vs. injected 
doses for all tissues were significantly greater for Se-Met than Na2SeO3. Possible reason 
could be related to the difference in the rate of mobilization from the site of injection. 
Although both Se forms are readily absorbed, compared with Na2SeO3 more Se-Met was 
mobilized from the site of injection to the different embryonic tissues. As more Se-Met 
were transported from the yolk to the different tissues, more Se as Se-Met was retained. 
Therefore, greater amount of Se can be directly incorporated in tissue protein for protein 
biosynthesis and storage. This mechanism elevates the levels of Se in the tissues, which 
helps elevate the amount of Se as Se-Met  (Henry and Ammerman, 1995).  In contrast, 
Na2SeO3 although is highly absorbed is not well retained in body tissues since its 
absorption is similar to that of a mineral (Wolfram, 1999).  
The observations in the current experiment were similar with those of Cary et al, 
(1973) and Scott and Thompson (1971). The differences observed in Se metabolism and 
tissue concentration as 1) Se as Na2SeO3 in excess of amount equivalent to certain 
binding sites maybe eliminated from the body whereas, 2) seleno-amino acids in excess 
of the primary binding sites may be incorporated into proteins. Se-Met incorporation in 
protein occurs because a chemical similarity exists between Se-Met and methionine 
which allows the body to use them interchangeably during protein biosynthesis, 
tRNAMet cannot discriminate between methionine and Se-Met (Schrauzer, 2000). Thus, 
any Se-Met that is present in excess can be used for protein synthesis such as the skeletal 
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muscles (Schrauzer, 2000).  On the other hand, Na2SeO3 that is not absorbed tend to be 
eliminated by the body. This could explain the difference the higher deposition of Se-Met 
than Na2SeO3. 
The influence of Se yolk injection at 10 d of incubation on liver Se is presented in 
Figure 5.1. Both Se sources linearly increased the liver Se concentration at d 20 of 
incubation. Increasing the dose likewise increased the Se uptake by the liver. However, 
the slope for Se-Met (0.082) is significantly higher (P = 0.012) compared with that of 
Na2SeO3 (0.02) (Table 5.4). This means that the rate of Se tissue accumulation is higher 
for Se-Met than Na2SeO3.  During incubation, the injected Se was transferred from the 
yolk to the liver, however, more Se as Se-Met was transported than Na2SeO3. This clearly 
shows that Se concentration in the liver is dependent on Se concentration injected as well 
as Se source. Surai (1999) and Surai et al., (1997), reported that GSH-Px had the highest 
activity at all phases of the chick development particularly in the liver. These authors 
have shown that the liver GSH-PX activity rises rapidly during d 10-15 of incubation. 
This is important because, Paton et al. (2002) noted that the greatest increase in the 
accumulation of Se occurred between d 10-15 of incubation when the average Se 
concentration was 0.05 µg/g. Thus, an increase in GSH-Px activity would require an 
additional maternal dietary Se (Hassan 1986; Surai, 2000). Therefore the increase in Se 
as Se-Met in liver afforded by in ovo injection would be beneficial to the embryo 
considering the previous statements. 
Meanwhile, Figure 5.2 depicted the effects of injecting Se on lung tissues. Similar 
with the liver Se, linear increases in lung Se resulted from injecting Se either as Se-Met 
or Na2SeO3. Again, more Se in the form of Se-Met was being delivered to the embryonic 
lung tissues via the yolk at day 20 of incubation than Na2SeO3. The increase in the slope 
of Se-Met is significantly higher (0.020 vs 0.070) than the increase for Na2SeO3 (P < 
0.001), meaning that the rate of tissue uptake is higher for Se-Met (Table 5.4).  
The increase in breast muscle Se from embryos receiving Se-Met injection at day 
10 of incubation is depicted in Figure 5.3. Tissue Se concentration for the breast muscle 
is similar to that of   heart muscle Se (Figure 5.4). There was a significantly greater rise in 
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the slope of the lung and breast muscle Se (Table 5.4) resulting from Se-Met injection in 
comparison with Na2SeO3, where P < 0.001. Overall, for the tissue Se concentration, the 
hand, Na2SeO3 that is not absorbed tend to be eliminated by the body. This could explain 
the difference the higher deposition of Se-Met than Na2SeO3. 
The influence of Se yolk injection at 10 d of incubation on liver Se is presented in 
Figure 5.1. Both Se sources linearly increased the liver Se concentration at d 20 of 
incubation. Increasing the dose likewise increased the Se uptake by the liver. However, 
the slope for Se-Met (0.082) is significantly higher (P = 0.012) compared with that of 
Na2SeO3 (0.02) (Table 5.4). This means that the rate of Se tissue accumulation is higher 
for Se-Met than Na2SeO3.  During incubation, the injected Se was transferred from the 
yolk to the liver, however, more Se as Se-Met was transported than Na2SeO3. This clearly 
shows that Se concentration in the liver is dependent on Se concentration injected as well 
as Se source. Surai (1999) and Surai et al., (1997), reported that GSH-Px had the highest 
activity at all phases of the chick development particularly in the liver. These authors 
have shown that the liver GSH-PX activity rises rapidly during d 10-15 of incubation. 
This is important because, Paton et al. (2002) noted that the greatest increase in the 
accumulation of Se occurred between d 10-15 of incubation when the average Se 
concentration was 0.05 µg/g. Thus, an increase in GSH-Px activity would require an 
additional maternal dietary Se (Hassan 1986; Surai, 2000). Therefore the increase in Se 
as Se-Met in liver afforded by in ovo injection would be beneficial to the embryo 
considering the previous statements. 
Meanwhile, Figure 5.2 depicted the effects of injecting Se on lung tissues. Similar 
with the liver Se, linear increases in lung Se resulted from injecting Se either as Se-Met 
or Na2SeO3. Again, more Se in the form of Se-Met was being delivered to the embryonic 
lung tissues via the yolk at day 20 of incubation than Na2SeO3. The increase in the slope 
of Se-Met is significantly higher (0.020 vs 0.070) than the increase for Na2SeO3 (P < 
0.001), meaning that the rate of tissue uptake is higher for Se-Met (Table 5.4).  
The increase in heart Se from embryos receiving Se-Met injection at day 10 of 
incubation is depicted in Figure 5.3. Tissue Se concentration for the breast muscle is 
similar to that of heart muscle Se (Figure 5.4). There was a significantly greater rise in 
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slope of the lung and breast muscle Se (Table 5.4) resulting from Se-Met injection in 
comparison with Na2SeO3, where P < 0.001. Overall, for the tissue Se concentration, the 
highest slope ratios for Se-Met: Na2SeO3 were observed with lung (2.9) and heart (3.6) 
tissues (Table 5.4).  
 This work demonstrates that injecting Se in ovo up to 40µg Se/egg as Se-Met or 
Na2SeO3 does not result in high embryonic mortality and abnormalities. The Se injected 
into the yolk either as Se-Met or Na2SeO3 is readily taken up by the embryonic tissues. It 
is also clear that Se-Met results in higher Se tissue accumulation compared with Na2SeO3 
on an equal amount basis. Taken together, the data presented on this work verified the 
earlier results we reported on our Leghorn eggs studies.   
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Table 5.1. Embryo livability (%) at day 18 and 20 of  incubation.1,2 
                   
                     Day18                      Day 20 
 Treatment dose                                     Se    Source 
   μg Se/egg                  Na2SeO3             Se-Met              Na2SeO3         Se-Met  
0           100  93  90  84 
2.5   98  98  90  89 
5   92  98  88  90 
10   96  92  86  80 
20   94  78  83  66 
40   78  82  71  72 
1Livability = (viable embryos ÷ fertile eggs set)* 100. 
2Significant effect: Dose. 
 
 
Table 5.2.   Effect of Se dose on embryo livability (%) at day 18 and 20 of   
                  Incubation.1,2 
 
Treatment Dose                                             Livability, % 
     μg Se/egg                          d 18                           d 20 
               
0                       97a   87a 
2.5    98a   89a 
5    95a   89a 
10    94a   83ab 
20    86ab   71b 
40    80b   71b 
P value   0.048   0.018 
SEM    5.73   8.11 
1Livability = (viable embryos ÷ fertitle eggs set)* 100. 
2Significant effect: Dose. 
  a-c: P < 0.05. 
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Table 5.3. Effect of in ovo Se injection on embryonic tissue Se concentration at 20 days 
                 of  incubation.            
 
 
 
Se Source 
 
            
   Dose 
μg Se/egg 
 
Tissue Se, μg/g 
 
Liver 
 
Lung 
 
Heart 
 
Breast 
Na2SeO3 0  0.979ef 0.237g 0.161f 0.162f 
Na2SeO3 2.5 0.871f 0.316fg  0.176ef 0.168f 
Na2SeO3 5 1.044ef 0.334ef  0.187ef 0.175f 
Na2SeO3 10     1.162ef 0.451d 0.261d 0.241de 
Na2SeO3 20 1.809d 0.415d  0.236de 0.355c 
Na2SeO3 40 3.260b 0.569c  0.3591c 0.569b 
Se-Met 0 0.893ef 0.265fg    0.194ef 0.181ef 
Se-Met 2.5 0.997ef 0.290fg 0.196ef 0.219def 
Se-Met 5 1.093ef 0.393de 0.294d 0.274d 
Se-Met 10 1.511de 0.420d  0.263d 0.355c 
Se-Met 20 2.567c 0.683b  0.533b 0.554b 
Se-Met 40 3.992a 1.039a 0.922a 0.869a 
 
Se Source 
Dose  
Source*Dose 
 
 P value 
 0.024 
 0.000 
      0.284 
 
P value 
0.000 
0.000 
0.000 
 
P value  
0.000 
 0.000 
       0.000 
 
P value 
0.000 
0.000 
0.001 
a-f : P < 0.05.
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Table 5.4. Comparison of slope between Se-Met and Na2SeO3 on tissue Se concentration. 
                   
 
Source 
 
Slope 
 
P value 
Liver        Se-Met 
                 Na2SeO3 
0.081 
0.060 
0.012 
Lung        Se-Met 
                 Na2SeO3 
0.020 
0.007 
<0.001 
Heart         Se-Met 
        Na2SeO3 
0.018 
0.002 
<0.001 
Breast        Se-Met 
        Na2SeO3 
0.017 
0.011 
<0.001 
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                       Figure 5.1.  Liver Se concentration (wet basis, μg/g) of at Day 20 of incubation. 
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                     Figure 5.2. Lung Se concentration (wet, basis, μg/g) at Day 20 of incubation. 
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                       Figure 5.3. Heart Se concentration (wet basis, μg/g) at Day 20 d of incubation. 
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                   Figure 5.4. Breast muscle Se concentration (wet basis, μg/g) at Day 20 of    
                                      Incubation. 
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CHAPTER 6: EFFECT OF IN OVO SELENIUM INJECTION OF BROILER 
BREEDER EGGS ON TISSUE SE CONCENTRATION, LIPID PEROXIDATION, 
IMMUNE RESPONSE AND POST HATCH DEVELOPMENT 
 
INTRODUCTION 
Lipid hydroperoxides when left unchecked can potentially damage the integrity of 
the cellular membrane and can lead to cell death. These peroxides are the preliminary 
oxidation products and are further decomposed to secondary products which are 
aldehydes including malonaldehyde. It has been shown that chick embryo has substantial 
levels of polyunsaturated fatty acids in the lipid fraction (Speake et al., 1998), which are 
susceptible to oxidation, and therefore needs antioxidant defense system (Surai, 1999).  
The tissues of the newly hatched chicks contain a variety of natural antioxidants 
including vitamins A, C, E and antioxidant enzymes such as superoxide dismutase (SOD), 
catalase (CAT) and Se containing glutathione peroxidase (GSH-Px). According to Combs 
(1981) α-tocopherol and Se are the primary factors in the modulation of oxidant 
protection. Selenium is a micronutrient that is essential to the nutrition of animals and 
certain pathologic conditions has been associated with deficiency in diet.  However, the 
effect of Se deficiency in animals was not completely explained until Rotruck et al. 
discovered the biochemical function of Se in 1973. Se is an integral and necessary 
component of glutathione peroxidase (Glutathione: H2O2 oxidoreductase E.C. 1.11.1.9), 
an enzyme that is responsible in the reduction of hydrogen peroxides (Mills et al., 1958) 
or fatty acid hydroperoxides (O’brien et al., 1969) and responsible for maintenance of 
sulfhydryls in the reduced state (Srivastava et al., 1970). Noguchi et al. (1973) 
demonstrated that day old chicks fed control diets without Se had higher lipid 
peroxidation than chicks fed a Se supplemented diet. The addition of Se and vitamin E in 
the chick diet also inhibited the development of exudative diathesis.   
  84 
Se-dependent-GSH-Px is found in the different cellular compartments (e.g., 
cytosol, extracellular space, cell membranes). Therefore, the antioxidant properties of 
selenium are present throughout the cell as well, participating in immune signaling. Se is 
essential for optimum activity of the immune system (Arthur et al., 2003). Deficiency in 
dietary Se impacts the competence of both the innate non-adaptive and the acquired 
adaptive immune system (Spallholz, 1990; Turner and Finch, 1991; Kiremidjian-
Schumacher and Roy, 1998; Brown and Arthur, 2001).  
Biswas et al. (2006) reported that dietary Na2SeO3 at 0.5 and 1 ppm increased 
antibody response against inoculated (sheep red blood cell) SRBC and mitogen response 
to phytohemagglutinin (PHA) measured as foot web index at 4 weeks compared with the 
basal diet (0.2 ppm Se) in Japanese quail; Se treatments had no effect on performance. In 
contrast, Gowdy and Edens (2003) reported that broilers fed organic selenium showed 
less T-cell-mediated wing web reaction to PHA compared with Na2SeO3-fed birds. In a 
related study, supplementation of Na2SeO3 in broiler produced no inhibitory effects on 
antibody production; however, all antibody titers for Se-supplemented broilers were 
significantly higher compared with the broilers fed a no Se-supplementation (Gowdy, 
2004). However, it was demonstrated by several investigators that addition of higher 
levels of Se improved the immune functions in young chicks (Biswas et al., 2006; Panda 
and Rao, 1994; Marsh et al., 1981). Larsen et al (1997) demonstrated that the addition of 
Se in diet enhanced the immune response of broiler against antigen challenge and 
reduced the effects of cold stress, 4.9 vs 2.4 log2 titers. The possible mechanism for the 
depressed immune function could be related to the effect of inadequeate Se and or 
vitamin E in the diets resulting to the primary lymphoid organ denegenaration which 
consequently led to the depletion of lymphocytes (Marsh, 1986, Peng et al., 2011a,b). 
 The present study was undertaken to evaluate the effects of in ovo selenium 
injection on broiler breeder eggs on tissue Se concentration, lipid peroxidation, immune 
response and post hatch development.  
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MATERIALS AND METHODS 
Experimental Animals and Treatment Groups 
This experiment was conducted at the Alltech-University of Kentucky Research 
Alliance Poultry Farm facilities at the Coldstream Experimental Unit in Kentucky. All 
procedures were conducted under protocols approved by the Institutional Animal Care 
and Use Committee (IACUC). Six hundred (600) Cobb 500 fertile brown eggs obtained 
from Cobb-Vantress, Monticello, KY were used for this study. Fertile eggs were 
incubated at 37.5°C and a relative humidity of 55 to 60%. Two sources of Se, 1) Se-Met 
2) Na2SeO3 and six Se doses were used (0, 2.5, 5, 10, 20 and 40µg/egg) to inject eggs.  
Two groups of 25 eggs were allotted to each injection treatments. Sham control eggs 
injected with phosphate buffered saline (PBS). All solutions were prepared in sterile PBS 
solution. Total weight of egg contents was approximately 40g. 
Preparation of Se Solutions 
Phosphate buffered saline (PBS) was prepared with Sigma PBS (10mM phosphate 
buffer, 2.7 mM KCl, 137 mM NaCl, pH 7.4) tablets according to manufacturer’s 
instructions and was autoclaved at 121°C for 45 min. Seleno-L-methionine (Sigma) or 
Na2SeO3 (Sigma®) was dissolved in PBS to make up a 600 ppm Se solution which was 
subsequently diluted with PBS to make up 400, 200,100, 50 and 25 ppm solutions. All 
solutions were filtered using a 0.22µ acetate/pre filter (MSI®). 
Se Injection Procedure 
At day-10 of incubation, eggs were removed from the incubator and candled for 
viability. Under the candler, the outline of the air cell was traced using a pencil and the 
location of the embryo marked. After disinfecting the eggshell with an alcohol swab, a 
small hole was drilled on the larger end of the egg, above the air cell. Using a 23 gauge, 1 
½” needle, 0.1ml of respective Se solution was injected into the yolk. The injection site 
on the eggshell was sealed with glue and eggs were placed back into the incubator with  
settings according to standard hatchery practices.
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Transfer to Hatcher at Day 18 
At day 18 of incubation eggs were carefully candled for viability prior to transfer 
to the hatcher. 
Day 20 Tissue Sample Collection 
At 20 days of incubation, eggs were pulled out of the incubator and cracked open 
for liver, lung, heart and breast muscle tissue collection. For each treatment groups, 5 
pooled samples of each tissue were collected according to each Se level injected. Samples 
were frozen at -20°C until analysis. 
Analytical Procedures 
Liver, lung and heart samples were analyzed for selenium content according to 
fluorometric assay by Olson et al. (1975) with modifications by Cantor and Tarino (1982).  
Three pooled samples of 5 tissues were used per treatment group.  
Birds and Diets  
At day of hatch, chicks were pulled out of the hatcher for pen placement. Two 
hundred and eighty eight Cobb® 500 broiler chicks were placed, allotting six birds per 
cage in a mesh wire-floored standard pullet starter cages (61 cm x 51 cm x 36 cm) in an 
environmentally controlled room. The temperature in the room was set at 31°C for the 
first week and adjusted to 27° for the remainder of the study. Continuous light was 
provided for 22h/day. Each cage was equipped with a one feeder, which is removable for 
weighing purposes and two adjustable nipple drinkers.  Feed and water were supplied ad 
libitum. This experiment used a randomized complete block design. Blocks were based 
on cage locations within the room. Each experimental unit was composed of one cage per 
six birds. Four replicate cages were assigned to each of the 12 injection doses used. 
Treatment doses were randomly distributed to cages within each of the four blocks.  
All birds were fed a low-Se corn-soybean meal diet with no Se or vitamin E 
supplementation.  The ingredient composition and the calculated nutrient analysis of the 
basal diet are given in Table 6.1. This experiment was conducted up to 21 days.  Birds 
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and feed was weighed initially and then on a weekly basis.  At the end of each week, 2 
birds per cage were euthanized by argon gas asphyxiation followed by cervical 
dislocation. Liver, lung, heart and breast muscle were collected weekly and stored at        
-20C until analysis. 
 
Table 6.1. Ingredient and nutrient composition of diet. 
Ingredients % in diet* 
  Corn 56.25 
Soybean meal, 48.5% protein 36.00 
Limestone, feed-grade, 38% Ca 1.33 
Dicalcium phosphate, 22% Ca, 18.5% P 1.75 
Iodized salt 0.45 
DL-Methionine 0.19 
Vitamin Mix 0.25 
Mineral Mix (No Se added) 0.25 
Corn or vegetable oil 3.53 
Total 100.00 
  Calculated nutrient composition 
  
Metabolizable energy, kcal/lb 3087 
Protein  22.00 
Calcium 1.00 
Phosphorus, available 0.45 
Methionine 0.51 
Methionine + Cystine 0.90 
Lysine 1.15 
Sodium 0.20 
*unless other unit given
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Laboratory Procedures 
Lipid Peroxidation of Whole Cell Homogenates Using Ascorbic Acid Stimulation1 
Tissue Sample Preparation 
Two (2g) of tissue sample (liver, lung, heart, breast muscle) was homogenize in 
20ml 0.174M KCl in 0.025M Tris-HCl buffer (buffer pH7.4) using a homogenizer. The 
homogenate was centrifuged at 400 X g for 10 mins and the precipitate was discarded.  
The supernatant were transferred into new 20ml conical tube. 
 
Lipid Peroxidation Stimulation Using Ascorbic Acid 
To the 0.5ml of the whole cell fraction was added with 1ml of 1.5mM ascorbic 
acid solution in Tris-KCl buffer + 1.5ml Tris-KCl buffer and incubated for 60 minutes at 
37°C. The reaction was stopped by adding 1ml of 20% TCA. For the control samples, 1 
ml of 20% TCA was added before incubation.  
Thiobarbituric Acid (TBA) Lipid Peroxide Formation Test 
 Samples were filtered using a #541 filter paper (Whatman®, Fisher Scientific, USA). 
Two (2) ml of filtrate was transferred in clean fresh tubes to which 1 ml of 0.67% TBA 
was added. Samples were then boiled (100°C) for 35 mins and cool completely in water 
for 5 minutes. Absorbance was read at 530 mu using a spectrophotometer (Shimadzu® 
Columbia, MD)  
 
Antibody Production by Sheep Washed Red Blood Cells (SRBC) 
 
 Sheep washed red blood cells (SRBC), 100% suspension (Lampire Biological 
laboratories, Pipersville, PA 18947) was used to stimulate an antibody response. Using 
two replicates per treatment, all birds from each pen were injected intravenously via the 
jugular vein with SRBC (1mL/chick of a 7% suspension in sterile phosphate buffered
                                                 
 
1 Modified from Noguchi T, A.H. Cantor, M.L. Scott. (1973).  
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saline solution) at 3 days of age.  Baseline titers were determined by collecting blood 
samples before SRBC injection. Blood samples were drawn via jugular vein at 7 and 13 
days post primary SRBC injection.  At 13d post primary injection, birds were given a 
booster injection (secondary) of SRBC (1ml, 7% SRBC) and blood samples were 
collected 4 days later to quantify anti-SRBC antibody titers. Sera were extracted and later 
were stored (-10°C) until analysis. Serum samples were heat inactivated at 56°C for 30 
minutes. Samples were analyzed for total, 2-mercaptoethanol-sensitive (ME-S) IgM and 
mercaptoethanol-resistant (ME-R) IgG. Antibody titers were expressed as the log2 of the 
reciprocal of the highest dilution showing 100% visible agglutination. 
 
Statistical Analyses 
Results were analyzed by ANOVA and Se source x dose treatment means were 
separated by the test of least significance (LSD). Linear regression analysis was used to 
compare the linear responses between the tissue Se concentration and doses of Se-Met 
and Na2SeO3 injected into the eggs (Statistix 9.0).  
 
RESULTS AND DISCUSSION 
Embryo livability at d 18 and 20 is shown on Table 6.2, while Table 6.3A showed 
livability at day of hatch. In ovo Se injection did not show any differences between 
treatments. However, a significant higher source effect was seen for Se-Met than 
Na2SeO3 (Table 6.3B) at day of hatch. In comparison with the previous embryo Se 
injection conducted in our laboratory (Macalintal et al., 2011b), embryo livability 
presented in the current study is lower. The difference observed in embryo livability with 
our previous broiler egg Se injection can be related to the age of the broiler breeder hens.  
In the current study, eggs were obtained from younger broiler flocks compared to the 
previous study. This is in agreement with the earlier findings on hatchability with hen age 
(Hulet et al., 2007; Bruzual et al., 2000; Noble, 1986; Vick et al., 1993; Fasenko et al., 
1992; O’Sullivan et al., 1991; Mauldin, 1989; Kirk et al., 1980). It has been reported that 
eggs from pullets at point of lay had lower hatchability than those eggs laid later in the 
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cycle (Shanawany, 1984; Mauldin, 1989). Noble (1986) noted a higher embryo mortality 
from younger flocks due to problems in yolk lipid assimilation and mobilization 
compared to eggs from older flock. Thus, the lower livability at d 18 and 20 reported here 
compared to our previous results, can be explained by the age of breeder hens where the 
eggs were sourced and not due to Se injection per se.  
Unlike other Se injection studies in the literature (Sukra et al, 1976; Palmer et al., 
1973; Kury et al., 1967; Halverson et al., 1965; Franke et al., 1936; Ridgway and 
Karnofsky, 1952), our experiment did not produce chicks that manifested the head, neck 
or appendage abnormalities. This finding is in agreement with our previous studies 
conducted in our laboratory utilizing white-shelled eggs. Thus, we cannot directly 
correlate Se injection with embryo lethality and abnormality since exposure to higher Se 
dose in our experiment did not result in such observations. The difference in the findings 
can be attributed to the quality of solutions used, day and route of injection as well as the 
quality of injection procedure. For example, Halverson et al. (1965) used non-sterile 
technique in their egg injection procedure except when eggshell was swabbed with 
1:1000 solution of tincture of merthiolate prior to injection. In addition, chorioallantoic or 
air cell injection decreased hatchability to 0 when eggs were injected with amino acids at 
d 7 or 13% when injected at d 0 (Ohta and Kidd, 2001; Ohta et al., 1999). Thus, the high 
embryo mortality observed in the Se injection studies in the literature using air cell route 
cannot be directly attributed to Se, if the above data were to be considered. In a study 
conducted by Tarantal et al. (1991), using long–tailed macaques, these researchers 
concluded that long-tailed macaque that were orally dosed with Se-Met at maternally 
toxic doses (up to 300 ug/kg-day) had progeny that did not show any terata. Apart from 
being different from the previous injection Se studies, our results are in contrast with the 
Se teratogenic effect from environmental Se exposure (Hoffman et al., 1988). In 1947, 
Rosenfeld, associated the abnormalities found in neonatal lambs from ewes that grazed in 
seleniferous areas to congenital microphthalmia. Hale (1937) associated similar defects 
found in offspring of livestock to vitamin A deficient forage. Ferm and co- workers 
(1990) concluded that in hamsters, only at doses of overt maternal poisoning i.e., >LD50 
and nutritional deprivation can lead to Se-Met induced embryonic toxicity. “Since the 
physiological basis of selenosis has not been defined and biochemical indicators have not
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been identified, it is difficult to distinguish levels of Se that are safe and beneficial to 
those that are potentially harmful to health “ (Ralston et al., 2008). For example, in 
aquatic birds, several researches have shown that elevated Se exposure can cause reduce 
reproductive success however; the threshold at which this negative effect is manifested is 
widely disputed (Adams et al, 2003; Fairbrothers et al., 2000; Ohlendorf et al., 1988, 
1989; Heinz et al., 1989; Williams et al., 1989). 
Body weights recorded at d 1, 7, 14 and 21 were not affected by the Se injection 
(Table 6.4). These results are comparable to earlier studies in which supplementation of 
Se has no significant effect on body weight gain or feed intake (Payne and Southern, 
2005b; Utterback et al., 2005; Paton et al., 2002, Cantor et al., 2000). 
Tissue Se concentrations for liver, lung, heart and breast muscle at d 7 is 
presented in Tables 6.5-6.6B. Tissue Se concentration for lung, heart and breast muscle 
were significantly higher when Se-Met was injected in ovo compare with Na2SeO3, 
however there was no difference in the liver Se. Tables 6.7 and 6.8 showed the Se 
concentration of the chicks at d 14 and 21 respectively. Only the lung Se showed 
significant difference for both Se source (Table 6.9A) and dose (Table 6.9B), in which 
Se-Met was higher P = 0.0001 (d 14) and P = 0.0342 (d 21). Egg formation and 
embryonic development in oviparous animals like chickens occur outside of the maternal 
reproductive tract. Oxygen exchange occurs via the air cell which is in direct contact with 
the outside environment.  Thus, chick embryos are constantly challenged by the effects of 
the outside conditions and may experience greater pulmonary oxygen tension than 
embryos developing in utero. GSH-Px activity, an Se dependent enzyme, in the lung 
decreases by 27% between 15 and 19 d of incubation and increased by the same amount 
by d 1 after hatching (Surai, 1999). In addition, Starrs (2001) reported that chick embryos 
subjected to low oxygen content (hypoxic environment) in the incubator (17.7 vs 20.7%) 
showed GSH-Px activity that was constant from day 14 to pip, and then increased 
significantly from pip to hatch. At d 19, respiration switches to pulmonary respiration. 
Therefore, an increase in GSH-Px activity could be beneficial to the embryo. In the 
current study, the lung Se concentration was maintained up to 21 days (P < 0.05). Thus, 
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the significant concentration of Se in the lung tissue is important if the above information 
were to be considered. 
Regression analysis for Se tissue concentrations at 7,14 and 21 d of age 
demonstrated that greater significant rise in slope was observed only at d 7 for the heart 
muscle. This was not seen in other tissues. 
Results for the measurement of the TBARS formation in all tissues collected at d 
20 of incubation is presented in Table 6.10. Lipid peroxides formed in tissue 
homogenates, mitochondrial or microsomal fractions after incubation as measured by 
TBARS assay has been has been in used for several years  (Raharjo et al., 1993; Willis, 
1969). Presence of lipid peroxides in cellular membranes had been linked to cellular 
damages, loss of cellular elasticity and decreased membrane fluidity (Padmaja et al., 
1997; Noguchi et al., 1973). For the current study, lipid peroxidation upon incubation 
with ascorbic acid observed in the lung and the heart was significantly lower when Se 
source was Se-Met than Na2SeO3, whereas the reverse was true for the breast muscle 
(Table 6.11A). According to Willis (1969), addition of ascorbate in tissue homogenate 
stimulates the formation of peroxides and is inhibited by glutathione. There was no 
difference seen in the liver except for the dose effect. Tissue homogenate from embryos 
that received the 0 μg Se from both Se source had the highest concentration of TBARS 
(Table 6.11B). Therefore embryos that received 0 μg Se had little natural protection 
against lipid oxidation compared to the Se-injected eggs. The oxidation products 
accumulated in tissues are metabolized by the natural antioxidants, such as vitamin A, C 
and E and the metabolic enzymes such as SOD, CAT and GSH-Px. (Surai, 2000). These 
compounds prevent the cellular insult than can damage the cellular membrane.  Noguchi 
et al. (1973) had previously reported that the mitochondria and microsomal fractions of 
day old chicks hatched from hens fed a low Se-vitamin E diet showed higher TBARS 
values compared to supplemented chicks. Protection against lipid peroxidation was 
afforded with selenium and vitamin E supplementation. In addition, complete prevention 
of exudative diathesis in these chicks was observed after 12 days of supplementation. 
According to Padmaja and Prasad (1997) a dose dependent relationship exists between 
the reduction of TBARS and Se concentration. They reported that the oxidation in the 
liver and brain homogenate of 14 d old chick embryos decreased as the concentration of 
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Se injected increased from 0, 12.5 (1.41 mg/g) to 37.5 (4.23 mg/g) μmoles Se/kg egg. In 
the same study, there was a significant increase in the activity of GSH-Px in the Se 
treated embryo. GSH-Px works by reducing lipid peroxide to lipid alcohols via the 
glutathione peroxidase.  Therefore dietary addition of Se elevates GSH-Px activity that 
tends to decrease lipid peroxidation. Omaye and Tappel (1974) also reported that chicks 
fed a Se enriched diet had increased GSH-Px activity compared Se-deficient fed chicks. 
Moreover, there is a linear relationship between GSH-Px activity and Se supplementation. 
 Selenium has been associated not only in the protection of cellular membrane 
against oxidative stress generated either endogenously or through the metabolic by-
products of free radicals, but also with its profound effects on immune response (Levkut 
et al., 2009; Biswas et al., 2006; Singh et al., 2006; Gowdy and Edens, 2003; Leng et al., 
2003; Brown and Arthur, 2001; Swain et al., 2000; Raza et al., 1997; Marsh et al., 1986; 
Spallholz, 1990; Turner and Finch, 1991; Kiremidjian-Schumacher and Roy, 1998; 
Colnago et al., 1984; Spallholz et al. 1973). The effects of Se in ovo injection of chicks at 
3 d of age against SRBC antigen response are shown on Table 6.12. Antibody titers were 
measured at 0,7,14 d post primary and 4 d post-secondary SRBC injection. Day 0 
represents the baseline titer, taken before injecting birds with SRBC. Sera were measured 
for presence of maternal or none specific antibody titers. For this experiment, d 0 resulted 
in no hemagglutination of SRBC, thus the presence of maternal or none specific antibody 
that can interfere with the testing was not detected. SRBC assay measures the antibody 
response to immunization with SRBC antigens, integrating the function of B lymphocytes, 
helper T lymphocytes and macrophages (Grasman, 2009). Hemagglutination occurs when 
the target antigens on the surface of the red blood cells clump together or agglutinate 
caused by the antibodies directed against them (Janeway et al., 2001). The highest serum 
dilution at which the concentration of antibody is sufficient enough to agglutinate the 
SRBC is expressed as the titer. In the case of this experiment, IgMs are presumed to be 
the antibodies sensitive to the denaturation of 2-mercaptoethanol while IgGs are resistant 
to it (Yamamoto and Glick, 1982). Antibody titers were not significantly different at 7 
and 13 d post primary and 4 d post-secondary SRBC injection (Tables 6.13A-6.13C). 
However, there was a trend observed at d 7 for all Se-injected birds, the IgM and total 
antibody titers were numerically higher than the control. The Se-injected chicks had the 
  94 
highest expression of IgM at 4 d post secondary SRBC injection. This is somehow 
similar to the result obtained by Larsen et al. (1997), where broilers fed graded doses 
(0.2-0.8 ppm) of Se did not show any in differences in antibody titer among these 
different doses. However, broilers fed a no Se or control diet expressed significantly 
lower response than the Se-fed broilers. In our case, the 3 d-old chicks that received 0 μg 
Se tended to have a numerically lower titer than the Se-injected birds. Despite showing 
no significant difference between the treatments, it was apparent that the Se injected 
incubating eggs had a tendency to elicit higher antibody response. 
The results of data presented here indicate that in ovo Se-Met injection, compared 
with Na2SeO3, resulted in higher hatchability, reduced lipid peroxidation in the lung and 
heart muscle and higher Se concentrations in heart and breast muscle through 7 days and 
lung though 21 days of growth.    
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Table 6.2.  Embryo livability (%) at day 18 and 20 of incubation.1 
           Day18                    Day 20 
 Dose                                    Source 
μg Se/egg                     Na2SeO3              Se-Met         Na2SeO3       Se-Met  
0            80  83  77  67 
2.5   77  77  75  75 
5   83  80  80  80 
10   75  92  72  86 
20   75  87  65  82 
40   58  87  52  80 
SEM        3.27                 3.06 
  ------------------------P values---------------------------- 
Source                 0.0769               0.0927 
Dose                    0.7393               0.4520 
Source x dose     0.3918                 0.2572 
1Livability = % viable embryos / fertile eggs set*100. 
 
 
Table 6.3A.   Embryo livability (%) at day of hatch. 1,2 
Dose, μg Se/egg           Na2SeO3                        Se-Met 
               
0                       72   64 
2.5    60   60 
5    62   66 
10    56   70 
20    54   62 
40    28   72 
SEM     2.65 
1Livability = % viable embryos / fertile eggs set. 
2Significant effect: Source (P < 0.05). 
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Table 6.3B.   Effect of Se source on hatchability of fertile eggs (H/F).  
Se Source           H/F (%) 
Se-Met    66a 
 
Na2SeO3    55b 
                                  
P value      0.02 
a-b : P < 0.05. 
 
Table 6.4. Effect of Se injection at 10 days of age on body weights of broiler chicks at 
1,7,14 and 21 days of age. 
 
 
Se Source 
 
 
Dose 
μg Se/egg 
 
Age in days 
1 7 14 21 
Na2SeO3 0 33 117 341 719 
Na2SeO3 2.5 34 117 334 736 
Na2SeO3 5 33 118 311 703 
Na2SeO3 10 34 119 346 739 
Na2SeO3 20 33 116 354 742 
Na2SeO3 40 35 118 360 726 
Se-Met 0 33 122 346 702 
Se-Met 2.5 33 120 342 719 
Se-Met 5 33 118 335 726 
Se-Met 10 34 119 345 738 
Se-Met 20 34 110 334 725 
Se-Met 40 33 123 361 779 
 
SEM 
P value 
  
0.542 
> 0.05 
 
4.80 
> 0.05 
 
15.75 
> 0.05 
 
26.02 
> 0.05 
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Table 6.5. Tissue Se concentration (wet basis, μg/g) of broiler chicks at 7 days of age 
injected with Se at 10 days of incubation. 
     Se 
Source  
Dose 
μg Se/egg  
Liver Se 
μg/g 
Lung Se 
μg/g 
Heart Se 
 μg/g 
    Breast Se,  
μg/g 
Na2SeO3 0 0.210  0.126cd 0.139c  0.137cde 
Na2SeO3 2.5 0.269   0.127bcd  0.150bc 0.132de 
Na2SeO3 5 0.306   0.131abc  0.157bc   0.146bcde 
Na2SeO3 10 0.282  0.125cd  0.160bc 0.168ab 
Na2SeO3 20 0.323  0.124cd 0.174b 0.129de 
Na2SeO3 40 0.372 0.115d  0.171bc       0.121e 
Se-Met 0 0.210  0.126cd 0.139c  0.137cde 
Se-Met 2.5 0.300 0.142a  0.172bc   0.154bcde 
Se-Met 5 0.309   0.131abc 0.175b   0.140bcde 
Se-Met 10 0.303   0.130abc  0.172bc   0.156abcd 
Se-Met 20 0.329  0.140ab 0.225a       0.184a 
Se-Met 40 0.429  0.126cd 0.257a  0.164abc 
         SEM 0.031 0.005 0.011 0.010 
                                                 P value 
         
Source  
Dose 
Source*Dose 
 
> 0.05 
0.001 
> 0.05 
 
   0.01 
> 0.05 
> 0.05 
 
0.0003 
0.0001 
0.0477 
 
0.010 
> 0.05 
0.0177 
Regression Analysis     
Comparison of Slope 0.630 0.333 0.030 0.630 
a-d : P < 0.05. 
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Table 6.6A. Effect of dose on tissue Se concentration of broiler chicks at 7 days of age 
injected with Se at 10 days of incubation. 
     Dose,  
μg Se/egg 
Liver Se 
μg/g  
Lung Se 
μg/g 
Heart Se 
μg/g 
Breast Se 
 μg/g 
0 0.210c 0.126 0.139c 0.137 
2.5 0.284b 0.135   0.161bc 0.143 
5 0.308b 0.131 0.166b 0.143 
10 0.292b 0.128 0.167b 0.162 
20   0.326ab 0.132 0.200a 0.157 
40 0.400a 0.121 0.212a 0.143 
SEM          0.022 0.003 0.011 0.004 
P value 0.001 > 0.05 0.000 > 0.05 
 a-c : P < 0.05. 
 
 
Table 6.6B. Effect of Se source on tissue Se concentration of broilers at 7 days of age 
injected with Se at 10 days of incubation.   
 
Se Source 
Liver Se 
μg/g  
Lung Se 
μg/g 
Heart Se 
μg/g 
Breast Se 
 μg/g 
Na2SeO3 0.294 0.125b 0.158b 0.139b 
Se-Met 0.313 0.133a 0.190a 0.156a 
SEM 0.126 0.002 0.0 0.007 
P value 0.321 0.009 0.000 0.010 
a : P < 0.05. 
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Table 6.7. Tissue Se concentration (wet basis, μg/g) of broiler chicks 14 at days of age 
injected with Se at 10 days of incubation. 
Se Source Dose 
μg Se/egg 
Liver Se 
μg/g  
Lung Se 
μg/g 
Heart Se 
μg/g 
Breast Se 
 μg/g 
Na2SeO3 0 0.229      0.162de 0.120 0.108 
Na2SeO3 2.5 0.228      0.168cde 0.125 0.106 
Na2SeO3 5 0.240      0.162de 0.130 0.105 
Na2SeO3 10 0.221      0.158e 0.130 0.105 
Na2SeO3 20 0.245      0.169bcde 0.134 0.121 
Na2SeO3 40 0.251      0.162de 0.145 0.124 
Se-Met 0 0.229      0.162de 0.120 0.108 
Se-Met 2.5 0.284      0.181ab 0.112 0.121 
Se-Met 5 0.256      0.169bcde 0.143 0.108 
Se-Met 10 0.233      0.178abc 0.135 0.119 
Se-Met 20 0.233      0.182a 0.154 0.125 
Se-Met 40 0.225      0.174abcd 0.139 0.118 
       SEM 0.021      0.003 0.011 0.008 
                                              P value 
    
Source 
Dose 
Source*Dose 
 
> 0.05 
> 0.05 
> 0.05 
 
0.0001 
0.0234 
> 0.05 
 
> 0.05 
> 0.05 
> 0.05 
 
> 0.05 
> 0.05 
> 0.05 
Regression Analysis     
Comparison of Slope 0.119 0.119 0.964 0.246 
a-e : P < 0.05. 
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   Table 6.8. Tissue Se concentration (wet basis, μg/g) of broiler chicks at 21 days of age 
injected with Se at 10 days of incubation. 
 
Se Source Dose Liver Se 
μg/g  
Lung Se 
μg/g 
Heart Se 
μg/g 
Breast Se 
 μg/g 
Na2SeO3 0 0.250  0.135de 0.135 0.100 
Na2SeO3 2.5 0.266   0.140cde 0.142 0.102 
Na2SeO3 5 0.242  0.135de 0.142 0.105 
Na2SeO3 10 0.263      0.131e 0.141 0.115 
Na2SeO3 20 0.272     0.142bcde 0.138 0.105 
Na2SeO3 40 0.240   0.135de 0.146 0.111 
Se-Met 0 0.250   0.135de 0.135 0.106 
Se-Met 2.5 0.274   0.153ab 0.140 0.110 
Se-Met 5 0.264      0.141bcde 0.151 0.114 
Se-Met 10 0.265     0.150abc 0.140 0.103 
Se-Met 20 0.289       0.155a 0.154 0.103 
Se-Met 40 0.298       0.147abcd 0.157 0.164 
       SEM 0.016 0.004 0.006 0.005 
 P value 
      
Source 
Dose 
Source*Dose 
 
> 0.05 
> 0.05 
> 0.05 
 
0.0002 
0.0342 
> 0.05 
 
> 0.05 
> 0.05 
> 0.05 
 
> 0.05 
> 0.05 
> 0.05 
Regression Analysis     
Comparison of Slope   0.100   0.459   0.331 0.720 
a-e : P < 0.05.
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   Table 6.9A. Effect of Se source on lung Se concentration on broiler chicks at 14 and 21 
days of age, injected with Se at 10 days of incubation. 
 
       a-b :  P < 0.05. 
 
 
Table 6.9B. Effect of Se dose administered on broiler chicks at 14 and 21 days of age 
after injecting Se at 10 days of incubation. 
 
    a-c : P < 0.05.
Se Source 
Lung Se, μg/g 
Day 14 Day 21 
     Na2SeO3 0.164b 0.136b 
Se-Met 0.174a 0.147a 
SEM 0.003 0.002 
P value 0.0001 0.034 
 
Dose, μg Se/egg 
D14  
Lung Se μg/g 
D21  
Lung Se μg/g 
0  0.162b                   0.135c 
2.5  0.174a   0.147ab 
5  0.165b   0.138bc 
10   0.168ab     0.141abc 
20  0.176a                   0.148a 
40   0.168ab     0.141abc 
SEM 0.003 0.003 
P value 0.023 0.034 
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Table 6.10. Effect of Se injection at on tissue lipid peroxidation at Day 20 of incubation. 
 
 
Se Source 
 
 
Dose 
μg Se/egg 
 
Thiobarbituric acid reactive substances, AU1 
      Liver      Lung Heart Breast 
Na2SeO3 0 0.004 0.0120b 0.0385b  0.0200bc 
Na2SeO3 2.5 0.003 0.0130a 0.0375b  0.0165cd 
Na2SeO3 5 0.001 0.0088f 0.0400b 0.0225b 
Na2SeO3 10 0.001 0.0105e 0.0265c 0.0065f 
Na2SeO3 20 0.001 0.0105e 0.0355b  0.0120de 
Na2SeO3 40 0.001 0.0120b 0.0540a  0.0155cd 
Se-Met 0 0.004 0.0125c 0.0385b  0.0200bc 
Se-Met 2.5 0.003 0.0020j  0.0175de  0.0200bc 
Se-Met 5 0.001 0.0115d  0.0245cd 0.0100ef 
Se-Met 10 0.001 0.0075i 0.0135c      0.0330a 
Se-Met 20 0.001 0.0080h 0.0270c 0.0120de 
Se-Met 40 0.0001 0.0085g   0.0210cde 0.0140de 
 
SEM 
 
 
Source 
Dose 
Source*Dose 
  
0.0007 
    
   P value 
> 0.05 
0.0053 
> 0.05 
 
0.0001 
      
    P value 
<0.0001 
<0.0001 
<0.0001 
 
0.0025 
       
      P value 
<0.0001 
  0.0001 
  0.0007 
 
0.0017 
   
    P value 
0.0178 
0.0031 
    <0.0001 
1 Absorption Units at 530 nm 
 a-j : P < 0.05. 
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 Table 6.11A. Effect of Se  source on tissue lipid peroxidation at Day 20 of  incubation. 
    
Se Source  
Thiobarbituric acid reactive substances, AU1 
      Liver      Lung Heart Breast 
   Na2SeO3 0.0022  0.011a  0.039a 0.015b 
Se-Met 0.0019  0.008b  0.024b 0.018a 
SEM 0.6213 0.000 0.001 0.007 
P value > 0.05        <0.001        <0.001 0.018 
1Absorption Units at 530 nm. 
 a-b : P < 0.05. 
 
 
Table 6.11B. Effect of Se dose on tissue lipid peroxidation at Day 20 of incubation. 
 
     Dose,  
μg Se/egg 
 
Thiobarbituric acid reactive substances, AU1 
      Liver      Lung Heart Breast 
0 0.0045a   0.0123a        0.0385a        0.0200a 
2.5 0.0032a   0.0075e  0.0275c    0.0183abc 
5 0.0010b   0.0101b  0.0323b  0.0163bc 
10  0.0012b   0.0090d  0.0200d  0.0198ab 
20  0.0012b   0.0093c   0.0313bc  0.0120cd 
40  0.0010b   0.0103b   0.0375ab 0.0148d 
SEM 0.0060         0.0001 0.0020 0.0020 
P value 0.005       < 0.001 < 0.001 0.003 
1Absorption Units at 530 nm. 
 a-e : P < 0.05 
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Table 6.12. Effect of in ovo Se injection on the antibody response to 
SRBC in 3-d old broiler chicks. The values are reported in log2 (2 
log reduction in titers). 
                     
         Days post primary injection 
  0 7 13 181 
 
      Days in age 3 10 16 22 
    Source 
 
Dose μg Se/egg Total Anti-SRBC Antibody Response 
  Na2SeO3 0 0 1 1 5.5 
Na2SeO3 2.5 0 2 0.5 7.5 
Na2SeO3 5 0 4 2.5 7 
Na2SeO3 10 0 3 0.5 6.5 
Na2SeO3 20 0 3.5 1 7 
Na2SeO3 40 0 2 1 7.5 
Se-Met 0 0 1 1 5.5 
Se-Met 2.5 0 2.25 1 5 
Se-Met 5 0 3.5 0 6.5 
Se-Met 10 0 2.5 1 8 
Se-Met 20 0 2 1 7 
Se-Met 40 0 3 0.5 5.5 
  
IgG Anti-SRBC Antibody Response 
Na2SeO3 0 0 0 1 2 
Na2SeO3 2.5 0 0 0 1.5 
Na2SeO3 5 0 0 1 6 
Na2SeO3 10 0 0 0 1.5 
Na2SeO3 20 0 0 0 2 
Na2SeO3 40 0 0 0.5 1 
Se-Met 0 0 0 1 2 
Se-Met 2.5 0 0 0.5 0 
Se-Met 5 0 0 0 1.5 
Se-Met 10 0 0 0 1.5 
Se-Met 20 0 0 0 2 
Se-Met 40 0 0 0 2 
  
IgM Anti-SRBC Antibody Response 
Na2SeO3 0 0 1 0 3.5 
Na2SeO3 2.5 0 2 0.5 6 
Na2SeO3 5 0 4 1.5 1 
Na2SeO3 10 0 3 0.5 5 
Na2SeO3 20 0 3.5 1 5 
Na2SeO3 40 0 2 0.5 6.5 
Se-Met 0 0 1 0 3.5 
Se-Met 2.5 0 2.25 0.5 5 
Se-Met 5 0 3.5 0 5 
Se-Met 10 0 2.5 1 6.5 
Se-Met 20 0 2 1 5 
Se-Met 40 0 3 0.5 3.5 
118 days post primary SRBC injection or 4 days post- secondary SRBC injection.
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Table 6.13A. Effect of in ovo selenium injection at 7 dpi1 SRBC immune challenge.  
  ------------------P values---------------------- 
  Total   IgG2  IgM 
Source   0.940     -  0.940 
Dose   0.235     -  0.235 
Source*Dose  0.601     -  0.601 
1dpi = days post primary injection. 
2 IgG = Not detected. 
 
Table 6.13B. Effect of in ovo selenium injection at 13 dpi1 SRBC immune challenge.  
   -------------------P values--------------------- 
                                        Total  IgG  IgM    
Source   0.172   0.071  0.522 
Dose   0.598   0.0003  0.555 
Source*Dose  0.001   0.0002  0.138 
1dpi = days post primary injection. 
 
 
Table 6.13C. Effect of in ovo selenium injection at 4 dp21 SRBC immune challenge.  
               -------------------P values---------------------- 
                                       Total   IgG  IgM    
Source   0.161   0.780  0.332 
Dose   0.492   0.174  0.121 
Source*Dose  0.199   0.068  0.026 
1dp2 = days post- secondary injection.
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Figure 6.1A.  Liver Se concentration (wet basis, μg/g) of broiler chicks at 7 days of age. 
                        
                      
                        
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.1B. Lung Se concentration (wet basis, μg/g) of broiler chicks at 7 days of age.  
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Figure 6.1C. Heart Se concentration (wet basis, μg/g) of broiler chicks at 7 days of age. 
                      
                      
                        
 
 
 
 
 
 
 
 
 
 
 
Figure 6.1D. Breast Muscle Se concentration (wet basis, μg/g) of broiler chicks at 7 days 
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Figure 6.2A. Liver Se concentration (wet basis, μg/g) of broiler chicks at 14 days of age. 
                       
                     
 
 
 
 
 
 
 
 
 
 
 
Figure 6.2B. Lung Se concentration (wet basis, μg/g) of broiler chicks at 14 days of age.
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Figure 6.2C. Heart Se concentration (wet basis, μg/g) of broiler chicks at 14 days of age. 
                       
                     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.2D. Breast Muscle Se concentration (wet basis, μg/g) of broiler chicks at 14      
                     days of age. 
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Figure 6.3A. Liver Se concentration (wet basis, μg/g) of broiler chicks at 21 days of age. 
                      
                     
 
            
 
 
 
 
 
 
 
 
Figure 6.3B. Lung Se concentration (wet basis, μg/g) of broiler chicks at 21 days of age. 
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Figure 6.3C. Heart Se concentration (wet basis, μg/g) of broiler chicks at 21 days of age. 
  
                    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 6.3D. Breast Muscle Se concentration (wet basis, μg/g) of broiler chicks at 21  
                      days of age. 
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CHAPTER 7: EFFECT OF SELENIUM SUPPLEMENTATION OF BREEDER 
HEN DIETS ON TISSUE SE CONCENTRATIONS IN PROGENY 
                         
 
INTRODUCTION 
Selenium is an essential trace mineral that is required by animals including 
poultry (NRC, 1994) for overall health and growth performance. The essentiality of Se 
was established when Schwarz and Foltz (1957) reported that Se is required nutrient that 
can prevent liver necrosis in rats.  Then in 1973, (Rotruck et al.) defined the specific role 
of Se as being part of the structural component of glutathione peroxidase (GSH-Px).  It 
has been shown that GSH-Px prevent lipid peroxidation by converting lipid 
hydroperoxides to non-toxic alcohol and water.  As free radicals are normally produced 
by the biological system, it is imperative that these radicals be quenched to prevent 
potential cellular damage. Cellular damages if left unchecked can often lead to 
pathological conditions. In poultry diets, Se is reportedly added to prevent exudative 
diathesis, pancreatic fibrosis, gizzard and heart myopathies, immune deficiency, reduced 
hatchability, reduced fertility and poor feathering among others (Cantor et al., 1975a, 
Scott et al., 1957; Schwarz et al., 1957; Patterson et al., 1957; Noguchi et al., 1973; 
Cantor et al., 1975b; Thompson and Scott, 1969; Gries and Scott 1972; Cantor et al., 
1982b, Scott et al., 1967; Arthur et al., 2003; Combs, 1994; Latshaw and Osman, 1974; 
Cantor and Scott, 1974; Edens, 1996). 
 The use of Se supplements for poultry diets was approved by the US FDA in 1974. The 
only two compounds of Se that were permitted were sodium selenite and sodium selenate. 
Then, in 2000, the FDA approved the use of an organic form of Se in chicken diets, 
namely selenium yeast which was described by Kelly and Power (1995). The major Se 
component of Se yeast is in the form of seleno-methionine, which is also chiefly found in 
cereals and grain used as feed ingredients. With the approval of the use of organic Se in 
poultry as well as other livestock, research studies have shown the effect of feeding 
organic Se as being superior in tissue Se accumulation than when NaSe2O3 is added to 
the diet.  Although, the concentration of Se found in cereals and grain varies according to 
geographical location in the US (Kubota et al., 1967).  Similarly, Cantor (1997) 
conducted a survey on Se levels of corn and soybean meal used as feed ingredient from 
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several US states. He reported that the average Se levels of corn ranged from 0.024 to 
0.42 ppm while the average Se levels for soybean meal was 0.06 to 0.08 ppm. Thus, the 
concentration of Se from corn and soybean meal varies from state to state. 
The essentiality of Se in the hen’s diet is important for egg production and 
hatchability as well as for the overall performance of progeny chicks as shown by Cantor 
and Scott (1974). Thus, maternal nutrition is critical to the growth and development of 
the incubating embryo. Chickens are considered as precocial species; such that all the 
required nutrients must be supplied to the egg prior to lay. Since embryos develop outside 
of the hen after the egg has been laid, it no longer has access to maternal nutrition except 
to what has been transferred to the yolk prior to lay. 
In a study conducted by Paton et al. (2002), it was shown that organic Se (Se 
yeast) as well as inorganic Se when added to the maternal diet could be transferred to the 
egg and subsequently to the embryo. This study showed that 0.3 mg/kg Se as Se yeast 
was transferred to the egg and the embryo significantly higher than NaSe2O3 on equal 
amount. These authors showed that deposition of selenium linearly increases with 
increasing Se concentration particularly with organic selenium. Furthermore, the greatest 
increase in the Se embryo concentration was between days 10-15 of incubation. Surai 
(2000) conducted a similar study showing that addition of Se yeast in the broiler breeder 
diet increased the Se status of progeny tissues.  These results lead us to the question on 
what happens to the tissue Se levels of embryo when they are hatched and grown for at 
least three weeks and fed a low Se diet.  
The objective of this experiment was to evaluate the effect of dietary Se 
supplementation of broiler breeder hens on the tissue concentration of progeny chicks fed 
a low Se diet. In addition, it was determined how long will enhanced tissue Se levels be 
observed in chicks-fed low Se levels when their dams are fed Se yeast. 
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MATERIALS AND METHODS 
Chicks and Diet 
Chick Study 
Chicks (straight run) used for this experiment were obtained from broiler breeders 
that were fed the following experimental diets; basal diet with no Se added and basal diet 
with 0.3 ppm Se either as NaSe2O3 or Se yeast.  Chicks were housed in mesh wire-
floored pullet starter cages (61 cm x 51 cm x 36 cm) with temperature of 31oC for the 
first week and 27oC for the remainder of the study. Each cage was provided with one 
feeder and two adjustable nipple drinkers. For the duration of the study, all chicks were 
fed a low Se broiler starter diets shown in Table 6.1. Water and feed were provided ad 
libitum.  
A completely randomized treatment arrangement was used for this experiment 
For Trial 1, there were 16 replicates of five chicks/cage based on maternal dietary 
treatment and for Trial 2, four replicates cages of five chicks per maternal dietary 
treatment were used.  
Animal Welfare 
This experiment was approved by the University of Kentucky Institutional 
Animal Care and Use Committee. 
Tissue Sampling 
Blood was collected via wing vein puncture and the collected blood was 
transferred to a vaccutainer containing heparin to prevent coagulation. For plasma 
extraction, blood samples were centrifuged for 15 mins at 2500 x g. Tissues samples such 
as liver and breast muscle as well as the blood were collected at days 7,14 and 21 or 22. 
Tissue samples were collected from two birds (pooled) from each of the four replicates 
per treatment whereas blood samples were collected intravenously from three birds from 
each of the four replicates/treatment. Samples were stored at -20C until analysis. 
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            Table 7.1.  Composition of broiler starter diet fed to all chicks. 
Feed Ingredient          Calculated Analysis 
Corn                           56.25%            Metabolizale Energy          1.39 Mcal/kg 
Soybean Meal            36.00%            Crude Protein                   22.4% 
Corn oil                 3.50%           Calcium                              1.01% 
Salt                0.45%           Available  Phosphorus       0.45% 
Methionine DL  99%    0.19%           Total Sulfur Amino Acid   0.90%                           
Vitamin mix*               0.25% 
Limestone             1.35% 
Dicalcium Phosphate    1.76% 
Mineral mix (no Se)      0.25% 
 
* Provided 33 IU Vit. E/kg 
 
Laboratory Analysis 
Plasma, blood, liver and breast muscle Se were analyzed using the fluorometric 
assay following nitric/perchloric acid digestion according to the procedures of Olson et 
al., (1975) with modifications by Cantor and Tarino (1982). 
Statistical Analyses 
All the data gathered from the experiments were subjected to ANOVA using the 
General Linear Model procedures for a completely randomized design experiment using 
Statistical Analysis System (SAS) software.  Differences among means were separated by 
the test of least significant difference. A probability of P < 0.05 was required for 
significance.    
RESULTS AND DISCUSSION 
The analyses for diets used for the current study showed that the semi-purified 
breeder diet with no Se added contained μg/g Se while the chick starter diet, indicated 
that it contained 0.035 μg/g Se.  
The effect of dietary addition of Se to maternal diet on the egg Se concentration is 
shown on Table 7.2. Dietary supplementation of Se significantly increased the egg Se 
concentration of eggs from Se compared to basal (no Se is added) treatment. While both 
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Se sources increased the egg Se, the addition of resulting egg Se level from Se yeast was 
37% greater than from NaSe2O3 (P < 0.001).  This result is in agreement with earlier 
studies on Se transfer to eggs  (Paton et al., 2002), in which graded additions of Se as Se 
yeast or Na2SeO3 linearly increased egg Se concentrations, Surai (2000) also reported 
similar findings, wherein the addition of 0.02 or 0.04 mg/kg Se as Se yeast to a breeder 
diet led to increase Se transfer to the yolk and albumen. This is important because, more 
Se in the yolk may be available for transport to embryonic tissues, hence, possibly 
improving antioxidant capacity. 
Results for Trial 1 are shown on Table 7.3 Adding Se as NaSe2O3 or Se yeast to 
the breeder diet significantly increased plasma Se and liver Se at Day 1, blood Se at Day 
13 and liver Se at Day 22 in chicks, compared to the control treatment. Compared with 
NaSe2O3, supplementing Se yeast resulted in significantly higher liver Se at Day1 (0.52 
vs 0.32 μg/g). 
In Trial 2, Se supplementation of the breeder diet with either NaSe2O3 or Se yeast 
significantly elevated blood, liver and breast muscle Se of chicks at Day 1. Se yeast 
resulted in significantly greater Se levels compared with NaSe2O3 (Figures 7.1, 7.2 and 
7.3). Se yeast but not NaSe2O3 also elevated blood and liver Se in chicks at Day 7. By 
Day 14, Se levels in blood, liver and breast muscle of chicks were similar for all 
treatments. Seleno-methionine is major component of Se yeast (Kelly and Power, 1995), 
Cantor and Tarino (1982) compared the effects of supplementing turkey diets with Se-
Met and NaSe2O3 on tissue Se. Seleno-methionine resulted in higher blood and 
erythrocyte Se concentrations. Payne and Southern (2005b) reported that feeding broiler 
chicks with organic Se and Na2SeO3 resulted plasma Se levels of 0.160 and 0.137 μg/g 
respectively. Our results for breast muscle Se concentration (Figure 7.3) are comparable 
with several earlier studies showing a significant increase in tissue Se accumulation due 
to supplements of Se yeast (Payne and Southern 2005b) or Se-Met (Cantor et al., 1982), 
compared with Na2SeO3. 
The highest increase in Se concentration was observed on d 1 when breast muscle 
Se for Se yeast treatment was 2x higher than that for NaSe2O3 (0.18 vs 0.09 μg/g). This is 
comparable to the results obtained by Pappas et al. (2006), who concluded that broilers 
breeders fed a high Se diet had progeny with higher liver and brain Se. Increased Se 
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status of hatched chicks persisted up to 14 days. Earlier on, Pappas et al., (2005) 
conducted a study in which progeny chicks hatched from breeders whose diets were 
supplemented with Se yeast (0.419 μg Se/g feed) were fed a low Se diet for 4 weeks. 
They observed that at day of hatch, breast Se was significantly higher in offspring (4.3 
times) from Se yeast supplemented hens than from control hens. The breast Se level 
dropped by d 7 but was still significantly higher than control birds up to 28 days. This 
trend was also seen in whole blood samples. Higher liver Se persisted up to 21 days in 
comparison with the other tissues.  
In the current study, Se supplementation of breeder hen diets resulted in a 
significantly greater maternal transfer of Se to progeny chicks. The results of this study 
showed that maternal supplementation of Se not only influences Se status of chicks at 
hatch but also during growth. This was evident by the differences in the tissue 
concentration of Se, while the chicks were fed low Se diets.  
Taken together, the results of this experiment showed that the progeny tissue Se 
levels in blood or plasma and tissues were all dependent on the amount and source of Se 
added to the maternal diet. The addition of adequate Se in the hen’s diet is prerequisite to 
elevating the Se status of embryo, and, thus, the chicks. Moreover, the addition of Se 
yeast further elevates tissue Se concentration compared with NaSe2O3. Finally dietary 
supplementation of Se is essential to prevent the possible Se deficiency that may occur in 
regions where Se levels in the soil and feed ingredient is low. 
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Table 7.2. Effect of Se supplementation on broiler breeder hen diets on egg Se levels.  
 
Breeder Diet                 Egg Se, μg/g,     % increase 
        wet basis  (vs Na2SeO3) 
        
Basal, no added Se    0.041c 
Basal + 0.3 ppm Se as NaSe2O3  0.185b 
Basal + 0.3 ppm Se as Se Yeast  0.253a                     37 
SEM      0.017 
P value     0.000 
 a-c : P < 0.05 
 
 
Table 7.3. Effect of Se supplementation of breeder hen diets on tissue Se concentration    
              (wet basis, μg/g) of  progeny chicks. (Trial 1) 
                  
Breeder Diet Se Source and Level             Plasma      Liver         Blood     Liver 
      Day 1        Day 1       Day 13    Day 22 
        
Basal , no Se added    0.018b         0.12c         0.04b       0.08b 
Basal + 0.3 ppm  Se as NaSe2O3  0.100a       0.32b         0.05a       0.11a 
Basal + 0.3 ppm Se as Se Yeast  0.100a       0.52a          0.06a       0.10a                    
SEM      0.009         0.038         0.003     0.006 
P value     0.006         0.001         0.029     0.012 
 a-c : P < 0.05 
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Figure 7.1. Effect of Se supplementation on of breeder hen diets on blood Se 
concentration (wet basis, μg/g) of progeny chicks fed a low Se diet. (Trial 2) 
  
Dietary Treatment Day 1 Day 7 Day 14 Day 21 
Basal, no Se added 0.03c 0.04 b 0.03 0.01 
Basal + 0.3 ppm Se  
as NaSe2O3 0.11
 b 0.04 b 0.03 0.01 
Basal + 0.3 ppm Se  
as Se yeast 0.16
 a 0.06 a 0.03 0.02 
SEM 
P value 
0.004 
<0.0001 
0.004 
0.012 
0.002 
0.140 
0.001 
0.079 
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Figure 7.2.  Effect of Se supplementation of breeder hen diets on liver Se concentration    
 (wet basis, μg/g) of  progeny chicks fed a low Se diet. (Trial 2) 
               
          
Dietary Treatment Day 1 Day 7 Day 14 Day 21 
Basal, no Se added 0.16c 0.09 b 0.08 0.07 
Basal + 0.3 ppm Se  
as NaSe2O3 0.35
 b 0.12 ab 0.08 0.07 
Basal + 0.3 ppm Se  
as Se yeast 0.68
 a 0.24 a 0.08 0.07 
SEM 
P value 
0.036 
<0.0001 
0.011 
0.021 
0.006 
0.905 
0.005 
0.783 
a-c : P < 0.05 
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Figure 7.3. Effect of Se supplementation of breeder hen diets on breast muscle Se         
(wet basis, μg/g) of progeny chicks fed a low Se diet (Trial 2).      
  
  
Dietary Treatment Day 1 Day 7 Day 14 Day 21 
Basal, no Se added 0.03c 0.04
  0.03 0.03 
Basal + 0.3 ppm Se  
as NaSe2O3 0.09
 b 0.06
  0.03 0.03 
Basal + 0.3 ppm Se  
as Se yeast 0.18
 a 0.06
  0.04 0.03 
SEM 
P value 
0.033 
<0.0001 
0.006 
0.075 
0.002 
0.242 
0.003 
0.181 
a-c : P < 0.05 
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CHAPTER 8: CONCLUSIONS                
 
 The purpose of this research was to investigate the effects of in ovo Se injection 
of incubating White Leghorn and broiler eggs as a possible means of enhancing Se status 
of chicks during embryonic and post-hatch development.  In the experiments, graded 
doses of Se-Met and Na2SeO3 were used to inject the yolk of fertile eggs after 10 d of 
incubation and determine the fate of Se once it has been absorbed and deposited into 
different embryonic tissues; its effects on embryo viability, lipid peroxidation, immune 
response and post hatch development.  
The first study (Chapter 3), using a solution containing 2.5, 5, 10 or 20 µg Se/g Se 
as Se-Met or Na2SeO3 dissolved in PBS were injected into the yolk of White Leghorn 
fertile eggs.  Embryo viability values for Se-Met were 97, 94, 90 and 83%, respectively, 
whereas the respective values for eggs treated with Na2SeO3 were 87, 94, 74 and 87%. 
Sham-control eggs injected with PBS had 94% embryo viability. Tissue Se levels 
increased as Se dose injected increased. Embryonic liver and lung from eggs injected 
with Na2SeO3 had higher Se concentration than from eggs injected with Se-Met. There 
was no difference observed in the heart Se levels from eggs injected with either Se.  
 In the second study (Chapter 4), White Leghorn fertile eggs were injected with 0, 
20, 40 or 60 µg Se/egg Se-Met or Na2SeO3 dissolved in PBS. Injecting fertile eggs up to 
60 µg Se did not negatively affect embryo livability. Embryos from eggs injected with 
Se-Met had higher viability than from eggs injected with Na2SeO3.  Linear increases in all 
tissues were obtained with increasing doses of Se. However, the change in heart and 
breast muscle Se concentrations was minimal above the 40 µg dose when Na2SeO3 was 
used. Linear regression coefficients for tissue Se vs. dose for all tissues were significantly 
greater for Se-Met than Na2SeO3. 
 In the third study (Chapter 5), 2.5, 5, 10, 20 or 40 µg Se/g Se as Se-Met or 
Na2SeO3 were injected into the yolk of broiler eggs to verify the results of the White 
Leghorn egg studies. Embryo livability at d 18 of incubation was significantly affected by 
dose. Livability ranged from embryo livability injected eggs ranged from 78-98 and 78-
100% for Na2SeO3 and Se-Met treatments, respectively. Injecting eggs with 20 or 40 µg 
  123 
Se/ egg resulted in decreased livability at both 18 and 20 d of incubation. However, no 
embryonic abnormalities were observed. Linear increases in all tissues were obtained 
with increasing doses of Se. Injecting broiler breeder eggs with Se as Se-Met or Na2SeO3   
up to 40 μg Se/egg at day 10 of incubation has little effect on embryo viability and 
injecting Se-Met results in greater tissue Se accumulation than injecting the same amount 
of Se as Na2SeO3. 
 In the fourth study (Chapter 6), the same injection doses as Experiment 3 were 
used. In addition, hatched chicks were grown for 21 days. Mean body weights at 1, 7, 14 
and 21 days of age were not affected by treatments. At 7 days of age, chicks from the Se-
Met injection treatments showed higher lung, heart, but not liver, Se concentrations in 
contrast to those from the Na2SeO3 treatments. A significant elevation in tissue Se due to 
injecting Se-Met was also seen after 14 and 21 days in the lung, but not in other tissues. 
Induced lipid peroxidation observed in the lung and heart was significantly lower for Se-
Met than for Na2SeO3. There was no difference seen in the liver except for the dose effect. 
Tissue homogenates from embryos that received the 0 μg Se had the highest 
concentration of TBARS, compared with other treatments. Immune response was 
measured following SRBC injection of chicks at 3 (primary) and 18 (secondary) days of 
age. Antibody titers were not significantly different at 7 days post primary and 4 days 
post secondary SRBC injection.  
In the fifth study (Chapter 7), chicks were hatched from broiler breeder hens fed a 
corn-soybean meal diet without Se supplementation or with 0.3 ppm Se as either 
Na2SeO3 or Se yeast. The Se status, as measured by tissue Se concentrations of progeny 
chicks was improved at hatching by supplementing breeder hens with either forms of Se. 
However, the improvement was greater with Se yeast, compared with Na2SeO3. 
The objective of this research was to study the effects of in ovo injection of 
graded levels of Se either as Se-Met or Na2SeO3 in fertile eggs after 10 d of incubation 
and determine the fate of Se once it has been absorbed and deposited into different 
embryonic tissues; its effects on embryo viability, lipid peroxidation, immune response 
and post hatch development. Previous studies on avian Se toxicity in the literaturee
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 reported that injecting Se in ovo resulted in high mortality and embryos with craniofacial 
and limb defects but this is not the case in the data presented in this dissertation. We 
cannot directly correlate Se injection with embryo lethality and abnormality since 
exposure to higher Se doses in our experiment did not result in such observations. The 
quality of solutions injected, the route and timing of injection as well as the quality of 
injection techniques can possibly explain the differences in the results gathered.  
The results of these experiments indicate that in ovo injection of Se up to 60 μg 
Se/egg did not prove to be detrimental to the developing embryos enough to produce 
developmental defects. Injecting graded doses of Se as either Se-Met or Na2SeO3 resulted 
in linear increases in tissue Se concentration. However, increasing the dose of Na2SeO3, 
above 20 μg Se resulted in minimal increase in heart and breast se concentration, 
compared with Se-Met. The effects on tissue Se concentrations suggest that these 
compounds are metabolized differently by the chick embryo.  Se-Met injection, 
compared with Na2SeO3, resulted in higher hatchability, reduced lipid peroxidation in the 
lung and heart muscle and Se concentrations in heart and breast muscle through 7 days 
and lung though 21 days of growth.  
The results of these studies indicate that injection of Se into the yolk of incubating 
eggs may be useful for enhancing Se status during embryonic and early post-hatch 
development. Thus, the improvement in Se status using this method in conjunction with 
dietary Se supplementation of breeder hens would be much greater than with only using 
dietary supplementation. 
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APPENDIX 1: Flourometric Determination of Selenium 
 
Reference: 
Olson et al., 1975 and Cantor and Tarino, 1982 
 
Principle: 
 
Samples undergo nitric/perchloric acid digestion, titration, reaction with 2,3 
diaminonaplthalene and extraction with cyclohexane. Cyclohexane layer is used to read 
relative fluorescence Using regression procedures, slenium conncetration in 
(micrograms) is determined. 
 
Apparatus: 
 
Analytical balance (readability to 0.0001g) 
Perchloric hood 
Glass Culture tubes with caps (200 x 25 mm) 
Turner Fluorometer Model 450 equipped with excitation filter #NB520 and emission 
filter #NB360 and apperture slides 1X,3X,10X and 30X 
Boiling water bath 
50C water bath 
 
Reagents: 
 
Nitric acid – certified ACS plus grade 
Perchloric acid 70%- reagent grade 
Ammonium hydroxide – certified ACs grade 
Hydrochloric acid – trace mineral grade 
 1:4 concentration 
 1:9 concentration 
 0.1N 
Hydroxylamine-EDTA solution 
In 1000 ml volumetric flask, dissolve 9 g disodium ethylene tetracetate in 900 ml 
water. Add 25 mg hydroxylamine hydrochloride, mix until dissolved. Dilute to 1 
L with water. 
Cresol Red 
Dissolve 0.05g cresol red in 1 ml water and add 1 drop ammonium hydroxide. 
Add 249 ml water; mix until dissolved. 
2,3 diaminonapthalene (DAN) solution 
Concentration needed is 1 mg/100 ml of 0.1N HCl. 5 ml is needed for each 
sample, standard and blank. Use 99% purity DAN. Prepare in amber bottle mix 
slowly with magnetic stirrer. Extract 3x with cyclohexane in separatory funnel 
prior to use; discard the cyclohexane layer. 
Note: DAN is light sensitive. When weighing DAN,turn off fluorescent light, 
yellow light may be used. 
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Procedures 
 
Sample preparation 
 
1. Weigh approximately 1 g of homogeneous sample into the culture tubes. Prepare 
samples in duplicate. 
2. Add about 3 glass beads to each sample. 
3. Add 15 ml nitric acid to tissue samples.  
4. Add 2.5 ml perchloric acid. 
5. For the nitric acid blanks ( prepare three), add 15 ml nitric acid and 2.5 ml 
perchloric acid to the culture tube. 
6. Cover with plastic wrap. Let stand overnight in fumehood. 
 
Standard preparation 
 
 Standards  do not undergo digestion and do not contain nitric acid. 
 
1. Prepare a selenium standard in triplicate. Curve should cover expected sample 
range. For the 0, use 1 ml of water and 2.5 ml perchloric acid. 
 
Digestion 
  
Fumehood with capacity to accommodate nitric acid and perchloric acid must be used in 
the procedure. 
 
1. Heat on Labconco digestors on low heat until deep orange  (nitric acid) fumes 
disappear. 
2. Increase heat when samples becomes transparent. 
3. The nitric acid is gone when sample volume reduses and clears. Perchloric fumes 
are dense and white and recirculate at the base of the flask. Once the perchloric 
fumes appear, heat sample 30 minutes to ensure nitric acid is completely gone. 
4. Cool sample in fumehood until fuming ceases. 
 
Boiling to titration 
 
1. Add 2.5 ml 1:9 HCl to all samples., standards and blanks; vortex. 
2. Heat uncoverd samples in boiling water bath for 25 minutes. 
3. Cool completely and add 100 ul of cresol red to each sample. 
4. In fumehood, add ammonium hydroxide dropwise to yellow point. Rinse inside of 
flask/tube with water. 
5. Add 1:4 HCl dropwise to orange endpoint (pH 1.5) 
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DAN reaction 
 
1. Add 5 ml DAN solution to each sample. 
2. Cover sample tubes with plastic wrap and heat in 50C water bath for 25 minutes. 
3. Remove from water bath and place in cool water bath. Cool completely. 
4. Add 8 ml cyclohexane. 
5. Tighly cap tubes and mix by slowly inverting covered racks for 1 minute. 
6. Bring cyclohexane level up in the tubes by adding 0.1N HCl. 
7. Using disposable tranfer pipet, transfer cyclohexane layer to borosilicate glass 
tubes, 12 x 75 mm. 
 
Fluorometer 
 
1. Install NB360 filter for excitation and NB520 fro emission wavelengths and 
aperture slides. 
2. Adjust to zero using black rod. Adjust to zero each time aperture slides are 
changes. 
3. Wipe each tube with Chemwipe. Read the standard curve, samples and blanks. 
 
Se determination 
 
Using regression procedures, generate the regression equation and calculate selenium 
concentration of samples.
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APPENDIX 2: Protocol for Lipid Peroxidation of Liver Whole Cell Fractions   
Using Ascorbic Acid  Stimulation 
 
Reference: 
 
modified from Noguchi T, Cantor AH, Scott ML. (1973).  Mode of action of selenium 
and vitamin E in prevention of exudative diathesis in chicks. J Nutr. 103(10):1502-11 
 
Principle: 
Samples are incubated with ascorbic acid to stimulate lipid peroxidation, presence of 
glutathione peroxidase inhibit the formation of lipid peroxides. Oxidation is measured by 
the formation of thiobarbituric acid reactive substances i.e., malonaldehyde.  
Apparatus: 
Tekmar® Homogenizer   Pipets 
Mistral® 2000, refrigerated centrifuge Pipette tips 
Water bath     Filter paper # 541 
Hot plate 
Culture tubes (12 x 75 mm) 
Beaker (4L) 
Volumetric flask (2L) 
Digital thermometer 
Wire baskets/ wire racks 
 
Reagents: 
0.025M Tris-HCl (157.6 g/mole) 
Weigh 7.88 g Tris-HCl and dissolve in 1700 ml deionized water. Adjust  pH to 
7.4. Transfer to 2 L volumetric flask and dilute to 2 L. 
 
0.174M KCl (74.56 g/mole) 
 Dissolve 12.97 g KCl in 1L 0.025M Tris-HCl buffer. Adjust pH to 7.4 
   
0.67%  Thiobarbituric acid (TBA) 
Dissolve 0.67g TBA in 100 ml deionized water. Do not refrigerate. Store in amber 
bottle with stirring bar. 
 
20% Trichloroacetic acid (TCA) 
 Dissolve 20 g TCA in 100 ml deionized water 
 
1.5mM ascorbic acid ( 176.13 g/mole)in Tris-KCL buffer 
 Dissolve 0.0528 g ascorbic acid in 200 ml Tris-KCl buffer
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Procedure: 
Sample Preparation* 
1. Homogenize 2g of tissue sample (liver, lung, heart, breast muscle) in 20ml 
0.174M KCl in 0.025M Tris-HCl buffer (buffer pH7.4) using a Tekmar® 
homogenizer. 
2. Centrifuge homogenate at 400 X g for 10 mins. (Mistral® 2000 refrigerated 
centrifuge) 
3. Transfer supernatant into a new 20ml conical tube and discard the precipitate. 
Note: samples and reagent should be on ice while performing the assay 
Lipid Peroxidation Stimulation Using Ascorbic Acid 
1. For time 60 samples, mix 0.5ml of the whole cell fraction in 1ml of 1.5mM 
ascorbic acid solution in Tris-KCl buffer + 1.5ml Tris-KCl buffer (use a 12 x 75 
mm borosilicate tube) 
2. For time 0 samples, pipet 0.5ml of the whole cell fraction and add 1ml of  20% 
TCA, vortex. Then add 1ml of 1.5mM ascorbic acid solution in Tris-KCl buffer + 
1.5ml Tris-KCl buffer 
3. Incubate samples at 37C for 1 hour in a water bath.  
4. Stop the reaction by adding 1ml of 20% (w/v) TCA in the time 60 samples. 
 
TBA (thiobarbituric acid) Lipid Peroxide Formation Test 
1. Filter samples using a whatman #541 filter paper (use the 16 X 125 mm 
borosilicate tubes) 
2. Transfer 2 ml of filtrate in a fresh clean 16 X 125 mm tubes then add 1 ml of 
0.67% TBA, 
3. Boil samples (100C) for 35 mins. 
4. Cool completely in water for 5 mins 
5. Read absorption at 530 mu  
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APPENDIX 3: Antibody Response to Sheep Red Blood Cell (SRBC) 
 
Reference:  
Gore, A.B. and M. A. Qureshi 1997. Poult. Sci. 76:984-991. 
Yamamoto, Y., and B. Glick. 1982. Poult. Sci. 61:2129-2132. 
Grimes S.E. 2002. ISBN 974-7946-26-2. 
 
Principle: 
At 3 d of age, birds fro each treatment groups will be injected, intravenously with 
1 ml of 7% SRBC, collect blood prior to inoculation. Blood collection will be at 7 and 14 
d post primary injection. At 14 d post primary challenge, all birds will be challenged with 
a secondary SRBC injection; blood will be collection will be at 4 d post-challenge. Anti-
SRBC injection titer will be calculated using micro hemagglutination and titers are 
expressed as log2 of the reciprocal of the highest dilution showing visible agglutination. 
Apparatus 
Microtiter Plate: “U” bottom, sterile 
Pipette tips 1-200ul capacity 
Multichannel pipettor 
Reservoir  
Water bath 
Reagents: 
Washed Sheep Red Blood Cell (100%)  
2-Mercaptoethanol (ME) 
 To 0.7 ml ME, add 99.3 ml deionized water 
Sterile PBS  
 Dissolve 2 PBS tablet in 250 ml deionized water.  
Procedure: 
Note: Heat inactivate samples at 56°C one day prior to analysis. 
For Total plate (PBS) 
1. Add 50 μl of PBS in the first row of the wells of the microtiter plate. 
2. Add 50 μl of serum sample in each well with PBS. 
3. Cover plates and incubate for 30 mins. at 37°C. 
4. Remove plates from incubator and add 50 μl PBS in the remaining well. 
5. Dilute samples, using multichannel pipetor, aspirate 50 μl from the first well and 
transfer into the second well.
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6. Mix 4-5x by pipetting up and down and then transfer 50 μl to the next well and do 
the same till the last well, discard the last 50 μl. 
7. Add 50 μl of 2% SRBC to all the wells. 
8. Cover and incubate for 30 mins at 37°C. 
9. Read immediately. 
For ME-titer (PBS/Mercaptoethanol) 
1. Add 50 μl on 0.01 ml merccaptoethanol in PBS in the first row of the wells of the 
microtiter plate. 
2. Add 50μl of serum sample in each well with ME/PBS. 
3. Cover plate and and incubate for 30 mins. at 37°C. 
4. Remove plates from incubator and add 50 μl PBS in the remaining well. 
5. Dilute samples, using multichannel pipettor, aspirate 50 μl from the first well and 
transfer into the second well. 
6. Mix 4-5x by pipetting up and down and then transfer 50 μl to the next well and do 
the same till the last well, discard the final 50 μl. 
7. Add 50 μl of 2% SRBC to all the wells. 
8. Cover and incubate for 30 mins at 37°C. 
9. Read immediately. 
Titers are read and recorded as ME-resistant (IgG). The ME-sensitive (IgM) is the 
difference between the PBS (Total) and ME-R readings. Total-ME-R=ME-S 
 
Note: Photograph of positive and negative titer readings can be found at 
            www. fao.org/docrep/005/ac802e/ac802e0a.html 
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APPENDIX 4: Blood Collection Through Venipuncture 
 
 
References: 
 
www. fao.org/docrep/005/ac802e/ac802e0a.html 
 
 
Principle: 
1. To obtain serum which will be tested SRBC antibodies, no anticoagulant is required 
and the blood is allowed to clot. The levels of antibody detected in individual birds give 
an indication of the response to SRBC challenge.  
Wing vein bleeding 
Materials 
• 2.5 mL syringes 
• 25 gauge needles for small chickens 
• 23 gauge needles for larger chickens 
• Cotton wool 
• 70 percent alcohol solution 
• Labels or marking pen to label each syringe 
 
Method 
1. Hold the chicken horizontally on its back. Hold the legs and place the other hand under 
the back to support the chicken. (Assistant) 
2. Pull a wing of the chicken out towards you. (Bleeder) 
3. Note the wing vein, clearly visible running between the biceps and the triceps muscles. 
The wing vein forms a V (bifurcates). Note the tendon of the pronator muscle that runs 
across the V. 
4. Pluck away any small feathers that obscure the vein. 
5. Disinfect the area around the bleeding site by swabbing with 70 percent alcohol. 
6. Insert the needle under the tendon. Direct the needle into the wing vein in the direction 
of the flow of blood. Do not insert the needle too deeply. Keep clear of the ulnar nerve. 
7. Once the tip of the needle is in the vein, gently pull the plunger of the syringe. Blood 
will flow into the syringe. If blood does not flow, release the plunger and make a very 
  133 
slight adjustment to reposition the end of the needle. 
8. Use a gentle suction to withdraw the blood to prevent the veins from collapsing. 
9. After removing the needle, apply pressure to the vein for a few seconds to discourage 
further bleeding. 
10. Transfer the collected blood into a vaccutainer and place it an angle in a rack 
facilitate clotting 
 
  Note: Chicken wing vein collection photograph can be viewed at  
            www. fao.org/docrep/005/ac802e/ac802e0b.jpg 
  
 
 
 
Blood collection via the jugular vein 
1. Hold the chicken horizontally on its back. Hold the legs and place the other 
hand under the back to support the chicken.(Assistant) 
2. Stretch out the neck with one hand away from you, remove some feathers 
along the neck area. The jugular vein is now visible. (Bleeder) 
3. Place the needle at an angle, bevel up, against the vein. 
4. Insert the needle through the skin. Direct the needle into the jugular vein in 
the direction of the flow of blood. Do not insert the needle too deeply. Keep 
clear of the trachea. 
5. Puncture the vein and slowly withdraw blood. 
6. Use a gentle suction to withdraw the blood to prevent the veins from 
collapsing.  
7. After removing the needle, apply pressure to the vein for a few seconds to 
discourage further bleeding. 
8. Transfer the collected blood into a vaccutainer and place it an angle in a rack 
facilitate clotting 
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